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CHAPTER 1 
INTRODUCTION 
AND 
OBJECTIVES 

1.1 Introduction. 
The sexually transmitted diseases (STOs) constitute a worldwide problem of major 
significance in terms of health. economic and social consequences [1]. 
The most important STOs are Ihe bacterial infections syphilis (causative agent 
Treponema pal/idum sub·species pallidum), gonorrhoea (causative agent Neisseria 
gonorrllOeae, N. gOllorrhoeae), infections caused by Chlamydia trachomatis (C. 
trachomatis) and the viral infections herpes genitalis (causative agent herpes 
simplex virus, HSV), condylomata acuminata (causative agent human papilloma 
virus, HPV) and human immunodeficiency virus infections including AIDS. In 
addition, donovanosis (causative agent Calymmatobacterium grallulomatis) and 
chancroid (causative agent Haemophilus ducrep) are important in the developing 
countries [2-4]. 
The combat against STOs is aimed at disrupting the infectious cascade. Attempts 
have been made to achieve this via education (for instance: safe sex campaigns), 
contact tracing, the screening of high-risk groups and treatment of patients. It was 
expected that this would decrease the spread of STOs in the community and 
prevent the development of complications and sequela in the individual patient [5-
8]. 
Correct diagnosis is of utmost importance. In addition to anamnesis and clinical 
presentation, the correct diagnosis of STDs relies on the detection of the various 
causative agents using the appropriate laboratory techniques. In symptomless 
infections such as gonorrhoea and C. trachomatis infections, such laboratory tests 
are the only means to trace the carriers. The treatment is of major epidemiological 
importance as it reduces the pool of clinically unsuspected, but infectious carriers. 
Traditionally, for N. gonorrhoeae-, C. trachomatis- and HSV infections the culturing 
of the relevant pathogen used to be the cornerstone in the laboratory diagnosis [9· 
16]. For the remaining STDs, culturing of the causative agents is either very difficult 
or impossible, and therefore, the laboratory diagnosis is based on the detection of 
appropriate antibodies against the causative agents [17-19]. 
An advantage of the culture techniques is the availability of the microbes for 
additional investigations such as the testing for susceptibility to various antibiotics 
that are used in the treatment of that particular STO, the sub·typing of HSV, the 
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sera-typing of C. Irachomalis and N. gonorrhoeae, the auxo-typing and screening 
for plasmids of N. gonorrhoeae. Such additional investigations may be valuable in 
understanding the clinical presentation and in deciding on the appropriate therapy. 
Moreover, the additional information can be used for epidemiological studies. 
A major disadvantage of the culture technique is the time-period between the 
setting-up of the cultures and the availability of the results. This requires the 
patients to return at least a second time. This is not feasible in settings where the 
patients have to travel a long distance to receive treatment and in populations with 
poor compliance. Moreover, the time needed for culturing delays therapy and 
prolongs the period of infectivity [20). A second disadvantage may be that the 
patient samples have to be transported to specialized laboratories. Despite the use 
of transportation media, the duration of transport and non-optimum temperature 
conditions during transport may adversely affect the results of the cultures [21-23). 
80th these disadvantages 01 the culture techniques formed the basis for 
investigating tile value of the Enzyme-Linked Immunosorbent Assay (ELISA) for the 
diagnosis of C. Irachomalis-, N. gonorrhoeal7 and HSV infections as a suitable 
alternative for the culture techniques. The ELISA is a very versatile method for 
detecting antigens and antibodies and offers the possibility for automation. It was 
hoped that the use of ELISA for detecting either antigens or antibodies may be 
useful in establishing the correct diagnosis of STDs. The latter type of ELISA is 
useful when insufficient antigen is available, as for instance, in the later stages of 
herpetic lesions and the late stage of herpes genitalis. 
1.2 Objectives of the study 
The objectives of the investigations described in this thesis were as follows. 
To compile a review on the clinical presentations of C. Irachomalis 
infections, gonorrhoea and herpes genitalis and on the methods used for 
their detection. 
To investigate the diagnostic value of methods in Wllich antigens are 
detected namely the non-marketed prototypes of ELISA kits for detecting C. 
Irachomalis infections, gonorrhoea and herpes genitalis. 
To develop a serological method for distinguishing herpes simplex virus 
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(HSV) type 2 infections in the genitalia from previous HSV type 1 infections. 
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CHAPTER 2 
INFECTIONS WITH CHLAMYDIA TRACHOMA TIS, NEISSERIA 
GONORRHOEAE AND HERPES SIMPLEX VIRUS 

2.1 INFECTIONS WITH CHLAMYDIA TRACHOMA TIS 
2.1.1 Introduction 
Chlamydiae are obligate intracellular bacteria with a unique growth cycle in which 
two forms of the Chlamydiae exist: the infectious Elementary Body (EB) which can 
survive outside the host cells and can infect new host cells and the Reticulate Body 
(RB) which multiplies intracellularly within a vacuole: the inclusion body. A part of 
the RB continues to multiply, whereas the larger part matures to EB. The infected 
host,c6'1 ruptures after 48-72 hours yielding new extra-cellular EB (1). 
Three species are distinguished among the Chlamydiae: C. trachomatis, C. psittaci 
and C. pneumoniae. C. trachomatis causes trachoma and STD and comprises 15 
different serotypes: the serotypes A-K and Ba, LGV 1, 2 and 3 [1). 
Trachoma is caused by serotypes A, B, Ba and C and is endemic in many 
developing countries, especially in densely populated areas where the hygienic 
conditions are poor. II is estimated that several hundreds of millions of people 
suffer from this disease and as a result, several millions have become permanently 
blind. The serotypes D-K cause sexually transmissible urogenital infections like 
urethritis or cervicitis and sometimes a mild conjunctivitis. The serotypes LGV 1-3 
cause the STD lymphogranuloma inguinale [2). The two latter diseases are 
reviewed below. 
2.1.2 Infections with serotypes D·K in men 
Infection of the male genitalia with C. trachomatis serotypes D-K may lead to ure-
thritis with dysuria and urethral discharge or may follow an asymptomatic course. 
The chlamydial urethral infections are milder and follow an asymptomatic course 
more often than gonococcal urethritis. Epididymitis occurs in 1-2% of the cases if 
the infection is left untreated [3,4). Men with chlamydia urethritis who have the 
major histocompatibility antigen HLA-B27 run a greater risk of devefoping Reiter's 
syndrome [5). In homosexual men, proctitis caused by C. trachomatis was 
observed. Infections of the rectum with serotypes D-K are milder than those with 
one of the LGV serotypes [6). 
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2.1.3 Infections with serotypes D·K in women 
The mucopurulenl cervicilis in women is Ihe counlerparl 01 non· gonococcal 
urelhrilis in men [7J. Uncomplicaled cervicilis moslly follows an asymptomalic 
course and dysuria occurs as a result of the infection spreading to the urethra. 
Endometritis. salpingilis and pelvic inflammatory disease (PID) occur as a result of 
ascending infection. Late complications are infertility or exlra·uterine gravidity due 
to fibrosis and adhesions in tile fallopian tubes. Perihepatitis (Filz·Hugh·Curiis 
syndrome) is also associated with chlamydial infeclion [8. 9J. In men and women 
conjunctivilis is also possible via contact of genital discharge·contaminated finger 
with Ihe eyes. 
2.1.4 Infections with serotypes D·K in children 
Neonales born from mol hers wilh genital chlamydial infeclion may become infected 
during parlus and may develop chlamydial conjunclivilis. The symploms usually 
manifesl belween 1 and 3 weeks poslnalal. The infeclion may have an 
asymplomalic course or may result in a purulenl conjunclivilis of varying severily. 
Severe sequela (corneal pannus and cicalrisalion of Ihe conjunclivae) may arise. 
Chlamydial pneumonia may develop if nasopharynx and respiratory Iracl are 
infecled. Prolonged cough and congeslion are Ihe major symploms which appear 
belween Ihe Ihird and Ihe elevenlh week [10·12J. 
2.1.5 Lymphogranuloma venereum 
Lymphogranuloma venereum (LGV) is caused by serolypes L 1·3 and is endemic 
in Africa. India. Soulh-Easl Asia. Soulh America and Ihe Caribbean. In the Weslern 
counlries Ihis disease has been imporled from the endemic areas. The symptoms 
may consisl of a primary leSion, usually an ulcus in lI1e ano-genital region and is 
followed by an inflammalion of Ihe inguinal lymph node(s) which evenlually may 
ruplure. However, the disease may also follow an asymplomalic course. The 
disease has usually no serious sequela, bul complicalions like proclocolilis, fislula 
formalion and elephanliasis of Ihe genilalia may occur [13J. The clinical and 
hislopalhological changes in early LGV proclocolilis and Crohn's disease are very 
similar [14,15J. In 2 of the 3 reclal biopsies from homosexual men with proclitis 
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caused by C. trachomalis of the LGV serotype, Quin et al observed 
histopathological changes which were consistent with those in Grohn's disease [16J. 
However, using the Polymerase Ghain Reaction (PGR), chlamydia-DNA could not 
be demonstrated in the DNA extracts from the gut samples of 10 patients with 
Grohn's disease or in samples from 4 controls [17J. 
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2.2 INFECTIONS WITH NEISSERIA GONORRHOEAE 
2.2.1 Introduction 
N. gonorrhoeae is a Gram·negative diplococcus which causes gonorrhoea. The 
gonococci can be distinguished from other Neisseriae using sugar fermentation 
tests and immunofluorescence techniques [1J. N. gonorrhoeae can be character· 
ized according to its amino acid requirements (auxo·typing) [2,3J or via its reactivity 
with monoclonal antibodies against epitopes of tile outer membrane protein (sero· 
typing) [4J. A relationship exists between the serotype on the one hand and the 
susceptibility to antibiotics and the localisation in a host on the other hand [5,6J. 
The presence of pili on the gonococcal surface has been related to the virulence 
[1,7J. N. gonorrhoeae may contain various plasmids of different sizes. The function 
of some plasm ids is known, for instance J3·plasmids of 2.9, 3.2 or 4.5 mD are 
responsible for the penicillin'resistance in the penicillinase·producing N. 
gonorrhoeae (PPNG) [8J. Higll level tetracycline· resistance has been ascribed to 
the acquisition of a streptococcal tetM determinant located on a 25.2 mD pfasmid 
[9,10J. Decreased susceptibility to penicillin, tetracycline and cepllalosporin is 
genetically determined [11 J. It has been suggested that inadequate tllerapies result 
in a selection of less susceptible strains of gonococci. The prevalence of antibiotic-
resistant strains is increasing and forms a major problem in the combat against 
infections with N. gonorrhoeae [1J. In the Western countries the prevalence of 
PPNG increased from 0 % in 1966 to 11 % (USA, 1991), 5 % (UK, 1990) and 12.7 
% (Australia, 1986) [12-15J. In some developing countries, tile prevalence of PPNG 
increased to 49 % (Gambia, 1989/1990) and 59 % (Zaire, 1988) [11,10J. In the 
Netherlands, the prevalence of PPNG increased from 9.6% in 1986 to 29.7% in 
1990 [16-18J. The prevalence decreased to 12% in 1992. The prevalence for 1993 
has been estimated to be 20% [van Klingeren, personal communicationJ. 
The properties of N. gonorrhoeae like auxo·type, sero·type and resistance to 
antibiotics may vary in time and geographicaf area [12J. This variability partially 
hampers the successful development of vaccines and diagnostic procedures. 
Effective therapy with cheap antibiotics such as penicillin and tetracycline is 
hindered in areas with a high prevalence of penicillin·resistant strains (10,19J. 
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2.2.2 Infections in men 
In men. uretilritis anterior is the most frequent manifestation of infection with N. 
gonorrhoeae. Symptoms of urethral discharge and dysuria usually appear within 
two to five days after infection [12.20J. Asymptomatic infections occur less fre-
quently in men than in women [21 J. Complications may include urethritis posterior. 
epididymitis, prostatitis, seminal vesiculitis and infection of the Cowper's gland and 
Tyson's glands. Ano-rectal inlections are mainly obsewed in homosexual men and 
are related to ano-genital sexual intercourse. 
2.2.3 Infections in women 
In women, the endocewical canal is Ihe most common location for infection with N. 
gonorrhoeae [21J. The urethra, the periurethral glands (Skene glands), the Bartho-
lin's glands, the rectum and the tonsils may also become colonized [12,21-23J. 
Uncomplicated inlection with N. gonorrhoeae frequently follows an asymptomatic 
course. Individuals with asymptomatic infections may unknowingly spread the 
infection lurther in the community. Complications of N. gonorrhoeae infection in 
women are bartholinitis, acute proctitis and pelvic inflammatory disease (PID). The 
long term sequela of salpingitis are infertility and ectopiC pregnancy. 
2.2.4 Pharyngeal infections 
Pharyngeal infections are less frequently obsewed in heterosexual men than in 
women and homosexual men. The most pharyngeal infections are asymptomatic 
and self-limiting. The role of pllaryngeal infection in the transmission of N. 
gonorrhoeae to sex-partners is uncertain [12J. 
2.2.5 Disseminated gonococcal infection 
Disseminated gonococcal infections are a complication of uro-genital gonorrhoea 
and occur more often in women than in men. The symptoms can be: arthritis, teno-
synovitis, dermatitis or a combination of these symptoms. The skin lesions mostly 
consist of a necrotic pustule on an erythematous base, but other manifestations are 
possible. The syndrome is often under-diagnosed because of the asymptomatic 
character of the preceding uro-genital infection [12,24,25J. 
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2.2.6 Maternal and perinatal infections 
The rates for premature delivery, perinatal distress and still birth were higher In 
mothers infected with N. gonorrhoeae than in uninfected mothers [6). 
Infection with N. gonorrhoeae in the newborn mostly results in conjunctivitis, but 
seldom in systemic infection [26). 
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2.3 INFECTIONS WITH HERPES SIMPLEX VIRUS 
2.3.1 Introduction 
The herpes viridae comprise a large group 01 DNA viruses found in many species. 
Six among them have been isolated from humans. Two of these, herpes simplex 
virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) are sexually 
transmissible microorganisms. HSV-1 and HSV-2 have 50% homology in the 
genomes and Ihe virions have many similar antigenic determinants. 
Both virus types can cause ano·genital as well as oral, facial and pharyngeal infec· 
tions, although HSV-1 is isolaled more often from the laller three locations and 
HSV-2 is isolated more often from the ano·genital region. 
HSV-1 is usually acquired during the first 10 years of life [1J. The large majority of 
the infections follow an asymptomatic course. About 10 % of the infections are 
accompanied by clinical manifestalions. In a sero·epidemiological survey in the 
USA, the prevalence of HSV-1 antibodies was 25 % in whiles and 70 % in blacks 
(2J. 
HSV-2 is usually acquired via sexual contac!. In a study in the USA, antibodies 
against HSV-2 were demonstrated in 19.7 % of the while population, in 64.7 % of 
the black population and in less than 1 % of the children under the age of ten 
years from both populations [2J. No such data are available on the prevalence of 
these antibodies in Europe. 
The virus remains present after asymptomatic or symptomatic infections. It is 
assumed that the virus retreats to the local ganglion and establishes a latent 
infection of neurons. Reactivation of latent virus causes recurrences which occur 
after nerve damage, trauma to the peripheral site receiving innervation from the 
latently infected ganglion or after immunosuppression (3J. 
It has been shown that virus may be shed during the symptomatic as well as the 
asymptomatic phases of the infections with HSV-1 and HSV-2 (3-5J. This release of 
virus particles may be important in the mode of transmission of especially HSV-1 
as a cause of genital herpes (6J. However, iI is assumed that the shedding of the 
virus from asymptomatic patients plays an important role in the transmission of 
genital herpes infections. 
In the Western countries, HSV is the most common venereal cause of genilal 
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ulcers [3J. [n the developing countries, other venereal causes such as syphilis, 
chancroid, LGV and granuloma inguinale are more important in the etiology of 
genital ulcers 17J. Genita[ ulcers have been implicated as a risk-increasing factor for 
acquiring human immunodeficiency virus 18J. Since HSV-1 and HSV-2 infections 
may occur in the same individual, it is convenient to use the following definitions: 
A first episode is the first period with clinical symptoms. This comprises a primary 
infection and an initial non-primary infection. A primary infection refers to an 
infection in a patient who has not suffered from previous HSV-1 or HSV-2 infections 
and therefore has no anti-HSV antibodies. 
An initial non-primary infection is a first symptomatic episode at a given anatomical 
site in a seropositive individual who has not suffered from a previous symptomatic 
episode at that location. 
A recurrence is a symptomatic episode at a given anatomical site at which a 
previous symptomatic episode with HSV had occurred 19J. 
2.3.2 Facial and oropharyngeal infections with herpes s[mplex virus 
Facial and oropharyngeal infections with HSVare frequently caused by HSV-1, but 
seldom by HSV-2 110J. Although these infections are not sexually transmitted, they 
are discussed here because of their role as a major source of genital HSV-1 infec-
tions 14-6J. 
The primary infection may progress asymptomatically or may cause gingivo-
stomatitis and/or pharyngitis. Facial skin may also be affected. The prodromal 
symptoms are typical and consist of itching or tingling sensations about 5 days 
prior to the appearance of the characteristic group of vesicles on the erythematous 
skin. After a few days, the vesicles change into erosions and heal after 5-10 days 
forming a crust. The primary infection may be accompanied by malaise and fever. 
After the primary infection, the virus retreats to the trigeminal ganglion where it 
remains latent. After reactivation under the influence of among others, sunlight, 
menses, fever, emotional stress or over-fatigue, the infection recurs and is mostly 
located on the lips or in the perioral region. A recurrence of herpes labialis is 
mostly more locat and has a less severe course than the first episode. However, 
sometimes the recurrent herpes infection may cover a major part of half of the 
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face. A disseminated infection (eczema herpeticum) may occur in patients with a 
pre-existing skin condition such as atopic eczema. Erythema exudativum multiforme 
(EEM) has been associated with herpes labialis. Recentfy, herpetic DNA was 
demonstrated in the skin biopsies obtained from lesions of patients with EEM 
[11,12). Infection of the eye may lead to a herpetic keratoconjunctivitis which in 
serious cases may lead to ulceration and blindness. 
Oropharyngeal herpes simplex virus infection in immunocompromised patients may 
lead to a persisting progressive ulcer, accompanied by necrosis, bleeding and 
severe pain. The infection may also spread to the oesophagus and the lower 
respiratory tract [13). Oesophagitis may occur after activation and spreading via the 
vagus neNe. Spreading of herpetic tracheobronchitis may lead to pneumonia. A 
disseminated infection accompanied by hepatitis, pancreatitis and encephalitis may 
occur due to viraemia after oropharyngeal and genital Ilerpes infection. 
2.3.3 Genitaf herpes simpfex virus infections 
Most genital herpes simplex virus infections are caused by HSV-2. HSV-1 was 
isolated from about 20% of the cases with primary genital herpes infections and 
from about 2% of the cases with recurrent infections [14J. Higher percentages of 
HSV-1 have been isolated from primary genital lesions in females under 25 years 
of age: from 45 % in 1985 to 65 % in 1988. The author suggested lIlat this can be 
explained by the delayed primary exposure to the virus, due to better hygienic 
conditions and due to the frequenter practice of cunnilingus relative to fellatio [6). 
Fifty to 70% of the genital herpes infections follow an asymptomatic course. 
Asymptomatic herpes infections occur more frequently in women than in men [14J 
and are often caused by HSV-2 [15J. In the USA, genital herpes infections with 
HSV-2 are reaching endemic proportions. fn urban areas 30-60% of the pregnant 
women from lower socioeconomic classes visiting an obstetric clinic possessed 
antibodies to HSV-2 [2-4,16-20). 
The incubation period of a primary herpes genitalis is 3-7 days. The severity and 
the duration of primary genitaf HSV-1 or HSV-2 infections do not differ [21). The 
first symptoms are mostly itching, redness and genital pain after which the vesicles 
appear on various parts of the genitalia. This is often accompanied by severe pain, 
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oedema, vaginal/urethral discharge, dysuria, urethritis and cystitis or cervicitis. The 
inguinal lymph nodes may be swollen and often there are general symptoms such 
as slackness, fever, headaches, muscular pain and dysuria [22,23]. After about 2 
days, the vesicles burst and ulcers develop which form crusts and heal after 10-21 
days. 
The duration of a recurrence is usually shorter, the symptoms are less severe and 
the area involved is usually smaller as compared willl a primary infection. Recur-
rences may continue to occur for many years and show a high individual variability 
of frequency and severity. More than 80 % of the patients with first episode of 
genital HSV-2 infection suffer from recurrences with an average of 4 times within 
the first 12 months. In contrast, 55 % of the patients with first episode of a genital 
HSV-1 infection suffer from a single recurrence during the same period [24]. A pre-
vious herpes labialis infection with HSV-1 partially protects against acquiring genital 
infection with HSV-1, but does not prevent it. Individuals with a first episode HSV-2 
infection who had already suffered from a previous episode of HSV-1 infection had 
fewer systemic symptoms, fewer lesions and a shorter duration of illness than 
patients with a primary HSV-2 infection [21]. 
Complications of a genital HSV-1 and HSV-2 infection may be: 
1. A self-limiting viral meningitis (particularty in primary herpes infection). 
2. Extragenital lesions: buttocks, groins, thighs, fingers and HSV conjunctivitis 
(primary and recurrent). 
3. Skin or visceral dissemination, thrombocytopenia, mono-arthritis and upper 
genitourinary tract infections in women. These complications are rare. 
4. Invasion of the sacral ganglion after genital or rectal herpes infection. This 
may cause a repeating lumbosacral herpes infection: besides the skin 
lesions on the buttocks, the sacrum or the hips, a dysfunction of the 
autonomic nervous system may arise and may be accompanied by anaes-
thesia, tingling sensations, urine retention, obstipation, pleocytosis in the 
liquor and impotence in men. 
5. In studies on the occurrence of HIV, the presence of genital ulcers, among 
others, was observed to be a risk-increasing factor for acquiring HIV 
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infection [25,26]. Vice versa, a HIV infection will worsen the course of a 
concomitant HSV infection. 
2.3.4 Foetal and neonatal herpes infections 
The foetus can be infected when the mother develops a disseminated infection. 
This infection may be lethal for the mother and her child [27]. In utero infection of 
the foetus due to an ascending genital herpes infection in the mother is unclear 
[28]. 
Infection of the neonate can occur during partus when the infant passes through 
the infected birth canal. HSV-2 has been isolated from 86% of the neonates with 
herpes neonatalis [29]. Postnatal infection can occur via handling of the neonate by 
an infected person. This infection is usually a HSV-1 infection. Postnatal infection 
caused by suckling from an infected breast has been reported [30]. 
Neonatal herpes infections can be divided into 3 categories according to severity: 
1. Local infections of the skin, the eyes and the mouth (SEM). 
2. Disseminated infection. 
3. Central nervous system (CNS) encephalitis. 
Most cases of herpes neonatalis infections can be recognized by the presence of 
skin, eye or oropharyngeal lesions [31]. 
The local infection has the best prognosis. The symptoms begin after 10-11 days. 
Groups of vesicles are observed at sites on the body that had been in direct 
contact with tile infected birth canal. Keratoconjunclivitis or oropharyngitis may be 
present. Later on, 30% of these children develop neurological symptoms: spastic 
quadriplegia, microcephaly or blindness and in one study, neurological sequela 
developed in 20-30% of the children [32]. The course is rarely lethal, but without 
therapy 75% of the local infections would progress to disseminated infection [33]. 
The mortality of disseminated infections is high (> 80%). Early recognition is of life-
saving importance [34]. The non'specilic symptoms of disseminated HSV infection 
begin after an average of 9 days and include lethargy, poor appetite, occasional 
apnoea, hepatomegaly and persistent acidosis. In this group, 45% of the children 
were born premature. Thereafter, hepalitis, pneumonia, insults and thrombocyto· 
penia develop. The child may die of presentations such as irreversible shock, 
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pneumonia or haemorrhagic diathesis. Skin, eye or mouth lesions are present in 
only 30% of the children with a disseminated HSV infection or HSV encephalitis 
(35). High dilutions of serum, that were found to be optimally effective in antibody-
dependent cellular cytotoxicity assays in the neonate or the mother, or high titres of 
HSV-neutralizing antibodies in the neonate could be related to the absence of 
disseminated HSV infections (36). 
The symptoms of HSV encephalitis mostly begin 11-20 days after birth. The 
symptoms include insults, irritability, poor lIuid intake, thermal instability, protruding 
fontanellae and pyramidal symptoms (37-39). The mortality is 50 % (40), the 
survivors often have neurological damage (41,42). A large majority of these children 
suffer from psycho-motoric retardation, microcephaly, hydranencephaly, spasticity, 
blindness or learning difficulties. The long-term prognosis with regards to the 
neurological sequela in children with HSV-l encephalitis is better than those with 
HSV-2 encephalitis (40). 
In view of the high mortality and the severe complications of neonatal herpes 
infection, one should be extra vigilant in identifying pregnant women at risk. First of 
all, these are the women with recurrent herpes genitalis, women with a partner with 
herpes genitalis and women who have suffered from an episode in the past. Forty 
percent of the neonates from women who had suffered an episode or who were 
suffering from primary herpes infection at the time of partus developed herpes 
neonatalis (32,43,44). Retrospectively, it was shown that primary infections with 
HSV-2 in the mother were responsible for half of the cases of herpes neonatalis, 
whereas the other half of the cases were observed to be due to reactivation of 
earlier infections (45). However, anamnestically a large proportion of the mothers 
who gave birth to children with herpes neonatalis, or their partners, were unaware 
of having suffered from a herpes episode (46,47). Thus, anamnesis alone is 
insufficient for tracing women at risk. Therefore, a serological test in which HSV-2 
specific antibodies can be detected would be valuable for tracing pregnant women 
at risk and their partners. 
It has been shown that negative results of cultures from the cervix of pregnant 
women at risk which were performed either early in pregnancy or weekly during the 
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weeks 32-36 did not exclude the occurrence of herpes neonatalis [48}. In contrast, 
it was shown that women who had positive cervix cultures during pregnancy often 
appeared to have negative cultures during delivery [49,50}. These contradictory 
results hamper the decision on an effective strategy to prevent herpes neonatalis. 
In the Netherlands, there is a consensus that pregnant women and their children at 
risk should be investigated. Samples for culture should be taken from the cervix 
and from sites of frequent recurrences from the woman "durante partu". Samples 
for culture from the infant should be taken from the nasopharynx. It is possible to 
obtain the results within the incubation period of approximately 4 days with the 
currently available culture techniques. As yet, there is no consensus on the 
approach that should be adopted in a neonate who is not yet ill, but in whom the 
culture is positive. One can begin treating the neonate prophylactically with 
Acyclovir or take a "wait and see" approach [51}. A major disadvantage of the 
procedures mentioned above is the difficulty in determining which women are at 
risk. 
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CHAPTER 3 
LABORATORY TECHNIQUES IN THE DIAGNOSIS 
OF INFECTIONS WITH 
CHLAMYDIA TRACHOMATlS, NEISSERIA GONORRHOEAE 
AND HERPES SIMPLEX VIRUS 

3.1 Introduction 
In general, the laboratory diagnosis of infectious diseases is based on the 
demonstration of the relevant microbes or parts thereof and/or the demonstration of 
specific antibodies in patient samples by means of serological tests. This is also 
true for the STD under investigation. The procedures for demonstrating the relevant 
microbes or their antigenic parts in patient samples, either directly or after culture 
are classified under antigen detecting techniques. In addition, newer diagnostic 
procedures which rely on the demonstration of relevant microbial DNA or rRNA are 
currently available. The diagnostic techniques whicll rely on the demonstration of 
specilic antibodies are classified under antibody detecting techniques. The current 
diagnostiC procedures are not discussed here as these have been reviewed 
extensively elsewhere [1·8J. This Introduction will focus on the test procedures that 
have been recently introduced for the diagnosis of the three diseases under 
investigation i.e. the procedures based on the ELISA methodology and those based 
on the molecular biology techniques. 
New diagnostic tests for diagnosis must fulfil several requirements. These have 
been reviewed by several authors [9·11J. One of these requirements is the 
evaluation of a new test by comparison with the "gold standard". As already 
mentioned in Chapter 1, culturing of the relevant microbes is the cornerstone of the 
laboratory diagnosis of infections with C. trachomatis, N. gonorrhoeae and HSV. 
Culturing of these microbes is currently used as the "gold standard". The latter can 
be described as one of the current test, that is generally accepted as being the 
best test available to distinguish between individuals with or without a certain 
characteristic feature. Two important features of diagnostic tests follow from this 
comparison: the sensitivity and the specificity. The sensitivity of a (new) test is the 
ratio between the individuals in whom this test is positive and all those in whom the 
"gold standard" is positive. The specificity of a (new) test is the ratio between the 
individuals in whom this test is negative and all those in whom the "gold standard" 
is negative. 
An ideal test should have high sensitivity and specificity. In addition, such a test 
should be suitable for monitoring the effectiveness of treatment. The results of such 
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a test after adequate therapy should be negative to allow clear-cut diagnosis of re-
infection. Such an ideal test does not exist. Therefore, it should be realized that the 
suitability of new tests would depend on the purpose for which it will be used. Two 
main purposes can be distinguished: the screening for disease in large populations 
and the clinical diagnosis. An important difference between both target groups is 
the prevalence of the disease. This is low in the population to be screened and 
higher in the case of clinical diagnosis. The prevalence affects the likelihood that a 
positive test result really indicates a truly positive individual (with disease) as well 
as the likelihood that a negative test result indicates a truly negative individual 
(without disease). Two additional parameters which indicate the probability of the 
correctness of a test result are the predictive value of a positive test result (PPV) 
and the predictive value of a negative test result (NPV). The PPV is the ratio 
between the number of individuals with a positive test result and the total number 
of individuals with the disease. The NPV is the ratio between the number of 
individuals with a negative test result and the total number of individuals without the 
disease. The PPV increases with increasing prevalence while the NPV decreases 
and vice versa. For screening, it is important not to miss individuals who are truly 
infected. Therefore, high emphasis is placed on the sensitivity of the test and on a 
high NPV. For clinical diagnosis, high emphasis is placed on a high specificity of 
the test and on a high PPV. 
In addition to these theoretical considerations, technical and economic aspects also 
playa role. These include technical simplicity, rapidity, the ease of performing IgM-
based diagnostic tests, suitability for automation and financial costs. When testing 
for infections with C. trachomatis, N. gonorrhoeae and HSV, the population to be 
tested (people attending the outpatient department for sexually transmitted 
diseases) has a high prevalence for these diseases. Here, the emphasis is placed 
on a high specificity and a high PPV. 
3.1.1 ELISA technique 
The laboratory diagnosis of infectious diseases is usually based on the demon-
stration of the causative agent andlor specific antibodies directed against (parts of) 
this agent. The latter is achieved via the reaction between the antigen and the 
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antibody. Such reactions require indicator systems to detect reactivity. These 
systems include complicated, vulnerable biological systems (i.e. the complement 
fixation reaction, passive haem agglutination) and fluorescent techniques in which 
the results have to be read using an appropriate microscope, but have the 
drawback that the readings are subjective. The formation of a visible precipitate in 
the antigen-antibody reactions which are performed in solution requires equivalent 
amounts of reactants. Deviations from equivalence can lead to false-negative 
reactions due to the absence of precipitate formation (i.e. prozone phenomenon). 
These problems can be circumvented by performing the antigen-antibody reaction 
on the surface of a solid phase to which one of the reactants has been adsorbed. 
The second reactant becomes attached to the solid phase via its reaction with the 
adsorbed reactant. After removal of the unbound material, the presence of the 
second reactant can be demonstrated by a labelled-detector which is specifically 
directed against the second reactant. A solid phase was used first in the solid 
phase radioimmunoassay. However, the use of radio labels required elaborate 
precautions, expensive appliances and appropriate measures for radioaclive waste 
disposal. The substitution of radio-labelled compounds by enzyme-labelled 
reactants and chromogenic enzyme substrates led to the development of the 
Enzyme-Linked Immunosorbent Assay [12J. The conjugates retain their 
immunological and enzymatical activity after coupling of enzymes to proteins 
[13,14J. In this technique, there is no need for the above mentioned precautions 
which has undoubtedly contributed to its wide-spread use. 
Several types of materials (polyvinyl, polystyrene, nitrocellulose and nylon) are 
suitable for use as a solid phase, because of their capacity to passively adsorb 
reactants. Most proteins including antibodies can be passively adsorbed to such 
solid phases. The nature of this binding is poorly understood. Hydrophobic and 
ionic interactions may be involved [15J. Antigens that have a poor binding capacity 
can be bound indirectly via chemical covalent binding to easily adsorbed proteins 
such as bovine serum albumin or high molecular weight polymers like polylysine or 
polyglutaraldehyde [16J. 
Especially, the plastics can be used in several forms such as microtitre plates, 
tubes, beads and micro-particles [17J. The choice of the material and form depends 
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on the type of the reaction, the financial costs and the possibility for automation. 
Membranes have a high functional surface·capacity. Nitrocellulose membranes 
have been used in dot-blot ELISA and nylon membranes for flow-through sample 
application in enzymeimmunofiltration assays. Microtitre plates and polystyrene 
beads are especially amenable for automation in standardized robotic systems. 
Free binding sites on the solid phase that remain after coating may produce high 
background staining by non-specific binding of one or more of the reactants. Such 
free sites must be blocked with an indifferent protein. Bovine serum albumin, 
casein, gelatin and non-fat dried milk have been used. 
The final signal in the ELISA is produced by an enzyme-substrate combination. 
The choice of a proper enzyme-substrate combination is dictated by the possibility 
to visualize the reaction via a change in colour. Frequently used enzyme-substrate 
combinations are alkaline phosphatase with p-nitrophenyl phosphate or horse 
radish peroxidase with o-phenylenediamine. More recently, several signal-
amplifying alternatives such as the biotin-strepavidin system have been developed 
[151. The colour change can be read by the naked eye or measured using a 
spectrophotometer. The intensity of the colour is a measure for the amount of 
antibodies present in the patient sample. 
The possibility to passively adsorb antibodies and antigens to the solid phase and a 
high flexibility in the manner of performance renders the ELISA technique suitable 
for application in the field of infectious diseases. 
Three types of ELiSAs have been used for the detection of antibodies in patients. 
In the indirect or sandwich ELISA, antigen is coated onto the solid phase. The 
antibodies in the patient sample binds to the coated antigen. Anti-human antibodies 
that are labelled with an enzyme are added and allowed to bind to the antibodies of 
the patient. Finally, the substrate for the enzyme is added and the enzyme 
reaction after having proceeded during a fixed time is stopped and the intensity of 
the colour developed measured. This ELISA principle can also be used for 
detecting antibodies in the sera from patients, using antigens which have been 
blotted or spotted onto nitrocellulose strips. However, Ilere the soluble colourless 
substrate (NBT/BCIP) is converted into a purple precipitate resulting in a purple dot. 
The reaction is read by the naked eye or measured using a densitometer. 
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In the competitive ELISA, enzyme-labelled antibodies specific for the antigen are 
incubated with the patient sample in wells of a microtitre plate coated with the 
antigen. The antibodies in the patient sample, if present, will compete with the 
enzyme-labelled antibodies for binding to the antigen. This results in a reduction of 
the colour in comparison with a negative control sample. The reduction in colour is 
a measure of the amount of antibodies present in the samples of the patients. 
The antibody capture ELISA can be used to identify antibodies of different immu-
noglobulin classes, for instance IgM. In this ELISA, the solid phase is coated with 
affinity purified antibodies specific for a class of human immunoglobulins. These 
immunoglobulins are captured from the added patient sample by the coated 
antibodies. After the removal of unbound material, antigen is added and will be 
bound by tile captured antibodies if they are present. The enzyme which produces 
the final signal may be bound directly to the antigen or to additional antibodies 
specific for the antigen (15). 
The ELISA methods for detecting antigen comprise the capture ELISA, the dot-
spot ELISA and the competition ELISA. 
In the capture ELISA, the antigen to be detected is captured from the patient 
sample added to wells of a microtitre plate or polystyrene beads coated with poly-
clonal or monoclonal antibodies. After waslling, a second antibody specific for the 
antigen and labelled with an enzyme is added. The developed colour after 
incubation with the substrate can be measured . 
In the dot-spot ELISA, the patient sample is passively adsorbed onto a nitrocellulo-
se membrane. In the direct version of this test, the antigen, if present, is detected 
by overlaying the spot with a specific enzyme-labelled antibody. In the indirect 
version the spots are first overlaid with unlabelled antibody specifically directed 
against the antigen, followed by an incubation with enzyme-labelled antibody, 
specifically directed against the first antibody. The reading of the reaction is the 
same as mentioned above for the dot-spot ELISA for the detection of antibodies. 
In the competition ELISA, antigen-enzyme complexes compete with the antigen in 
the patient sample for the binding by specilic antibodies coated onto the solid 
phase. This results in a decrease in the absorbance as compared with negative 
controls, measured using a spectrophotometer. In this method, a large amount of 
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purified antigen is required and therefore it is not routinely used for testing for 
STDs. However, the produclion of large amounts of antigen is possible with the 
currently available recombinant DNA technology. 
3.1.2 Molecular biology techniques 
New molecular biology techniques have been used in the diagnosis of STDs. 
Strands of DNA of interest, together with a cloning vector DNA are cleaved will) the 
same restriction endonuclease. This enzyme produces complementary single 
stranded ends on the foreign DNA and the vector DNA. These ends anneal and 
are ligated with a DNA ligase. The recombinant molecule is inserted into the 
appropriate host usually E. coli strain K 12, by transfection or micro-injection. The 
vector should have a selectable marker gene (for instance tetracycline resistance) 
to distinguish between transformed and untransformed host cells. The host cell 
should preferably be easy to culture and rapidly growing for a rapid multiplication of 
the DNA of interest. 
The newly synthesized DNA can be used as probes for the hybridization technique 
and for sequence analysis. The knowledge of the sequence can be used for the 
synthesis of primers and probes for use in the polymerase chain reaction (peR). 
Large quantities of the protein is produced when the corresponding gene is 
expressed in the host cell. This is of special interest for the production of antigens 
of microbes such as T. pallidum and human papilloma virus (HPV), which cannot 
be cultured on artificial media, antigens from microbes such as M. luberculosis with 
very low growth rate or when the purification of the antigen is very laborious or has 
a very low yield. For instance, Glycoprotein G for detection of herpes simplex virus 
type-specific antibodies is expressed in recombinant-baculovirus-infected insect 
cells or in E. coli [18,19). 
Hybridization technique 
In 1977, the HPV genome was cloned in bacterial plasmid vector and available for 
mapping and typing of HPV from various anatomical sites using hybridization [20). 
This is done with homogenized lissue biopsies using Southern blotting or dot 
blotting. In Southern blotting, the purified DNA from patient samples is first 
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electrophoresed in a gel and then blotted onto nitrocellulose. In the dot blot 
technique, the DNA is directly spotted onto a nylon or nitrocellulose filter. The DNA 
on the filter is probed with "P-Iabelled cloned HPV-DNA. The results are visualized 
by autoradiography [21 J. In the in situ hybridization technique, viral DNA or RNA 
can be detected in specific cells in tissue sections by using labelled DNA-probes 
[22-24J. Since then, these techniques have also been used for diagnosis of other 
STDs and are described further in the appropriate sections of this chapter. 
The polymerase chain reaction 
The peR is used for amplification of selected DNA sequences from selected 
material to enable detection with probes. Using this technique, small amounts of 
specific DNA can be detected. The method requires a knowledge of tile nucleotide 
sequences flanking the target DNA in order to generate oligonucleotide primers 
which mediate cycles of DNA synthesis. After denaturation of the target DNA and 
annealing of the primers, template-directed incorporation of deoxynucleoside 
triphOsphate occurs after the addition of the heat-stable DNA polymerase, Taq 1. 
The newly synthesized DNA strands may sewe as templates themselves and 
repeated cycles of denaturation, primer annealing, and extension result in many 
million-fold increase in the number of copies of the region flanked by the primers. 
Generally 25-40 cycles are performed within three to four hours using an 
automated thermal cycling device. The amplified DNA in its single stranded form is 
detected by hybridization with the appropriately labelled probes [25J. 
A critical feature of the peR is the specific annealing of the oligonucleotide primers 
to their complementary target DNA sequence and their subsequent extension. The 
design of primers of appropriate sequence is therefore, of paramount importance 
for successful amplification. The specificity may be a problem when the target DNA 
is present in a sample that also contains many other closely related DNA 
sequences. This may be overcome using "nested" primers in a second reaction 
tube. These match sequences just inside the two original primer sites. Thus 
"nested" amplification of a product in the peR depends on the accurate 
recognition by the four independent oligonucleotides [26J. 
The peR also has some other disadvantages. One problem is the ease with which 
47 
spurious amplification products may arise due to contamination from extraneous 
sources, This may be overcome by the use of closed systems, In addition, the 
number of pathogens cannot be quantified accurately using PCR, For instance, for 
diagnosis of an acute infection caused by Cytomegalovirus (CMV) or Epstein Barr 
virus, accurate quantification is desirable because the virus is present in small 
amounts in sero-positive but asymptomatic individuals, This is in contrast to the 
PCR for HIV in which the detection of even one viral particle is important [27J, 
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3.2 LABORATORY TECHNIQUES IN THE DIAGNOSIS OF INFECTIONS WITH 
CHLAMYDIA TRACHOMATIS 
3.2.1 Antigen detecting techniques 
Direct identification of Chlamydia in infected secretions 
Direct identification is performed microscopically using stained smears of patient 
material on microscopic slides [1). Initially. the smears, which usually contained low 
numbers of inclusion bodies and large numbers of elementary bodies (EBs), were 
obseNed after staining for inclusion bodies with iodine or Giemsa stain. However, 
the sensitivity of the method was very low because of the low number of inclusion 
bodies. Evaluation of the smears by an indirect immunofluorescent technique using 
polyclonal antibodies was unsatisfactory because of the high background staining. 
The use of monoclonal antibodies (MoAbs) prevents the background staining and 
allows a reliable identification of EBs in smears of infected secretions. Two MoAbs 
have been used thus far. The MoAb against the genus-specific lipopolysaccharide 
(LPS) epitope also reacts with Staphylococcus aureus protein A and with antigenic 
determinants of Gram-negative bacteria [2,3}. The Moab against the species-
specific major outer-membrane protein (MOMP) reacts with the EBs. The anti-
MOMP MoAbs may cross-react with other bacteria. This is a serious drawback for 
investigating samples obtained from the rectum. However, samples obtained from 
other parts of the body are less contaminated and the method can be used 
successfully [4-6J. 
The results of 24 studies in Wilich the anti-MOMP MoAbs were used were analyzed 
in a review [7}. The cut-off point for a positive test result varied from 1 to 10 EBs 
per preparation. The specificity decreased when the cut-off point was low, but the 
sensitivity did not necessarily increase. However, adequate sampling is very 
important: for ceNical samples, containing up to 5 endoceNical cells, the sensitivity 
was 70 %, for ceNical samples containing more than 5 endoceNical cells the 
sensitivity was 92 %. The overall sensitivity obseNed for endoceNical samples 
varied from 56 % to 100 %. The overall sensitivity for samples obtained from 
urethra of men varied from 49 % to 100 %. 
The advantages of this method are that the quality of sampling can be evaluated, 
the sensitivity is not reduced by transportation and the test is easy to perform. 
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However, the microscopic evaluation of the preparations requires a certain amount 
of experience and the reading of a large number of preparations is tedious. 
Culture of Chlamydia trachomatis 
In 1957, C. Irachomalis was cultured for the first time on the yolk-sacs of chick 
embryos using samples from the eyes of a patient with trachoma [8). In 1965, 
Gordon and Quan were the first to describe a method for culturing Chlamydia on 
monolayers of continuous cell lines [9). Nowadays, the most commonly used cell 
lines are the McCoy and Hela 229 cell lines for culturing Chlamydia using samples 
from urethra, cervix, rectum, oropharynx and the eye. The presence of Chlamydia 
in the inoculum is determined by the formation of inclusion bodies within the 
cultured cells. Their formation is stimulated by centrifuging the inoculum onto the 
monolayers [10), by including anti-metabolites (cycloheximide, iododeoxyuridine and 
cytochalasine B) to promote the formation of giant cells and by pretreating cells 
with a polycation (OEAE dextran) to reduce their negative surface charge. The effi-
ciency of culturing can be improved further by adding an initially infected, but dis-
rupted monolayer to a fresh monolayer (blind passage). The presence of inclusion 
bodies is read microscopically after staining the fixed monolayers with iodine or 
Giemsa. The sensitivity of culturing is increased even more by staining the infected 
monolayers with fluorescein isothiocyanate (FITC)·labelied monoclonal antibody 
[11). Culturing C. Irachomalis is cumbersome and time·consuming (72 h). The 
exact sensitivity of culturing on cell lines is unknown. The sensitivity was estimated 
to be ± 77% after repeatedly culturing a few samples from the cervix [12). In 1984, 
Schachter estimated the sensitivity of culturing a single specimen to be between 
70% and 80% in women with cervical infection and to be 90% in men with urethritis 
[13). The specificity of culturing is high because of the characteristic morphology of 
the inclusion bodies in the infected cells. Efficient culturing of Chlamydia is 
hampered because of loss of infectious material when samples from the patients 
have to be transported under non·optimum conditions [14). 
Antigen detection by ELISA methods 
From the various commercially available kits, two have been extensively evaluated. 
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In Ihe Chlamydiazyme test kit (Abbott Diagnostics, USA), samples Irom the patients 
are treated with detergents to extract the chlamydial genus-specific LPS antigen. 
Polystyrene beads are added to the extract which results in the binding of the LPS 
to the beads. After rinsing, the beads are incubated with a polyvalent rabbit anti-
LPS antiserum. The beads are incubated with a peroxidase labelled anti-rabbit 
immunoglobulin conjugate after washing. Subsequently, after rinsing, the beads are 
incubated with the appropriate substrate for the peroxidase and the absorbance is 
read spectrophotometrically. 
In the IDEIA (Boots-Celltech Diagnostics, UK), the wells of a 96·well polystyrene 
microtitre plate are coated with anti-LPS monoclonal antibody. The LPS-antigen 
extracted from the samples of the patients as described for the previous test is 
added to the wells. The antigen, if present, is captured by the coated anti-LPS 
antibodies. The presence of antigen is detected in a manner similar to that 
described for the previous test. 
A third test, the Test Pack Chlamydia (Abbott laboratories, USA) is a commercially 
available ELISA test based on the capture principle. Polyclonal antibodies against 
chlamydial antigens are coated onto the solid phase and are used to capture 
chlamydial antigens from the samples of the patients. The antigen, if present is 
detected with a detector system in which polyclonal antibodies are used. This test 
is simpler to execute than all the other tests. The results are obtained in 30 min 
and its execution does not require any special expensive equipment (e.g. spectrop-
hotometer) which makes it suitable for use in small laboratories. Although in an 
initial stUdy [15J, a sensitivity of 76% and a specilicity of 99.5% were observed, the 
test still requires further evaluation. 
In Chapters 5 and 6 the performance of the ELISA methods is evaluated further. 
3.2.2 Nucleic acid detecting methods 
Recently, a non·radioactive nucleic acid hybridization assay (PACE 2 assay, Gen-
Probe, San Diego, USA) has appeared on tile market. In tllis assay, C. trachomatis 
rRNA from patient samples is solubilized in a special buffer and is subsequently 
detected using the chemiluminescence·labelled probe. The results in women were 
comparable with those of cultures on monolayers. In two studies, the sensitivity and 
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the specificity of the modified version (PACE 2) were observed to be 95,2% and 
98,2% [16J and 93% and 98% respectively [17J, In one study, the sensitivity in men 
was observed to be 77,2%, It was suggested that this lower sensitivity could have 
been due to a more cumbersome sampling technique in men [16J, 
In the polymerase chain reaction (PCR), a primer that is common for C, tracho-
matis plasmid [18-21J or common for rRNA [19,22J are mostly used, Initially, there 
was concern regarding the specificity because of the risk of contamination with 
DNA from the laboratory [23J, This was overcome by using a closed system, In 228 
clinical samples, Ostergaard observed that in comparison with culture, the PCR had 
a sensitivity of 100% and a specificity of 93 %, By comparing the PCR results with 
the combined results of culture and IDEIA (Boots-celltech, UK) to identify the C, 
trachomatis infected patients, the PCR had a specificity of 99% [20J, In 216 men 
with non-gonococcal urethritis, Ratti observed a sensitivity of 100% and a specificity 
of 96,8% as compared with culture, The sensitivity of culture in comparison with the 
PCR waS 92.4% [18J, Bobo used an enzyme immunoassay (PCR-EIA) to 
demonstrate amplified DNA. One hundred and four cervical samples were 
investigated with PCR-EIA and culture, Forty-six of these 104 cervical samples 
were positive both in PCR-EIA and in culture, An additional 2 samples were 
observed to be positive in the PCR-EIA [22J, From the 168 samples from the 
patients (62 men and 106 women), Naher observed 30 samples to be positive both 
in the PCR and in culture, An additional 16 samples were observed to be positive 
in the PCR. On dilutions of suspensions of C, trachomatis laboratory strains, the 
PCR appeared to be a hundred times more sensitive than culture [21J, In the 
studies mentioned above, the sensitivity of the PCR was invariably 100 %, The 
specificity of the PCR in these studies was lower than the specificity of the culture, 
This indicates that tile culture technique is not able to detect all individuals carrying 
C, trachomatis, This is supported by the results of the additional tests that were 
performed, This challenges the role of culture as the "gold standard", The question 
still remains whether such a sensitive test would not detect residual DNA from 
dead microorganisms and would not remain positive for prolonged periods afier the 
patient has received adequate antibiotic treatment. However, in follow-up studies, 
Claas et al [19J and Ostergaard et al [24J observed no residual chlamydia-DNA 
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using PCR after adequate antibiotic treatment. This demonstrated that the PCR 
was suitable for monitoring the effectiveness of therapy. 
In conclusion, PCR is more sensitive than culture and also has a high specificity 
when appropriate precautions to exclude contamination are taken. 
3.2.3 Antibody detecting techniques 
Three test have been developed for the detection 01 anti-Chlamydia antibodies. 
These are Complement Fixation Test (CFT), Immunofluorescence Test (IF) and 
Enzyme-linked Immunosorbent Assay (ELISA). 
Complement Fixation Test 
Genus-specific chlamydial LPS antigen that is produced in embryonated hen eggs 
is used as an antigen in the complement lixation test. The test is of little value for 
detecting uncomplicated C. trachomatis infections because of its low sensitivity of 
15 % in uncomplicated urethral infections in men and 40 % in uncomplicated 
cervical infections [13}. The test is valuable in the diagnosis of pSittaCOSis and 
lymphogranuloma venereum (LGV). The results of the test were positive (titre 
>1:10) in more than 80% of the cases with LGV [25}. 
Immunofluorescent Tests 
In the Inclusion Fluorescent Antibody Assay (IF test), inclusion bodies from a single 
serotype in cell cultures on slides is used as the antigen. Antibodies against 
Chlamydia are detected by overlaying the slide with the serum of a patient. An-
tibodies, if present, are detected by a Ituorescent conjugate. The test has a higher 
sensitivity than the complement fixation test. The sensitivity was 82 % in men and 
95 % in women as compared with culture. However, 50.2 % of the female controls 
and 27 % of male blood donors were positive in this IF test [26}. Later, it was 
suggested that the high rate of positive results in the controls was due to the thus 
far underestimated frequency 01 infections with C. pneumoniae [27}. In this test a 
distinction between the antibodies against C. psittaci and those against C. 
trachomatis is not possible and in this respect, the IF test offers no additional 
advantages over the complement fixation test [26}. 
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In the type-specific micro immunofluorescence test (MIF), the elementary bodies of 
C. trachomatis serotypes A-K and LGV types 1-3 harvested from infected egg yolk 
sacs are fixed to glass slides and used individually as antigens [28J. This is a very 
laborious test. Therefore, it was attempted to simplify the test by pooling the 
antigens [29,30J. A further simplification consisted of the use of purified EBs of one 
serotype, namely the rapidly growing and broadly cross-reacting LGV-2 as an 
antigen. Peterson et al compared this Single-Antigen Microimmunofluorescence 
Assay with the Inclusion Fluorescent-Antibody Assay with serotype LGV-2 as the 
antigen. The correlation between these two assays was poor [31J. In the Chlamydia 
spot-IF test (Bio Merieux) which is commercially availabfe, the elementary bodies of 
C. trachomatis serotype LGV-2 and C. psittaci are coated separately onto a micro-
scope slide. It was claimed that using this test it was possible to distinguish 
between C. trachomatis and C. psittaci infections. However, Mannion compared the 
results of this test with those of the MIF. He observed that the test as supplied by 
the manufacturer was not suitable for distinguishing both types of antibodies [32J. 
Taken together, the simplified test procedures appeared unsatisfactory in 
diagnosing uncomplicated chlamydial infections and in distinguishing between 
infections caused by C. trachomatis and C. psittaci. In complicated infections also 
they are of limited value. 
Therefore, the MIF in its original form is the only useful test, but is used only at a 
few research laboratories. It is useful for detecting IgM, IgG and local secretory 
antibodies by using immunoglobulin class-specific fluorescein-labelled conjugates. 
Antibodies of the IgG class against C. trac/lOmatis may persist for many years and 
they were detected in 25·45 % of the normal adults, in 20-25 % of the 
asymptomatic sexually active males, in 50-70 % of the asymptomatic sexually 
active females and in more than 85 % of the prostitutes attending a STD clinic [13J. 
For this reason, MIF performed only once is not useful for diagnosing recent C. 
trachomatis infection in patients attending STD clinics. Only a seroconversion or a 
fourfold or higher increase in the titre of IgG in consecutive serum samples or the 
presence of IgM antibodies indicate a recent infection [33J. In patients with pelvic 
inflammatory disease, this strategy does not apply because most patients have 
suffered from a chlamydial cervicitis or salpingitis [34J. 
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The MIF test has been successfully used for the diagnosis of trachoma and for the 
diagnosis of C.trachomatis infection in infants [35-37J. 
Antibody detection by ELISA methods 
The lack of sensitivity of the CFT and the difficulty in performing the MIF test has 
prompted the search for new serologic tests for detecting chlamydial antibodies. 
Lewis et al. used intact Chlamydia of a laboratory strain of C. psiltaci in an ELISA 
and showed a diagnostic rise in antibody titre in all of the 14 patients with clinically 
diagnosed psittaCOSiS during an outbreak of this disease. The mean titres were 
higher for ELISA (419) then for CFT (94), indicating a higher sensitivity for the 
ELISA. Sera of 6 individuals wi III clinical LGV were also positive in the ELISA 
indicating that the assay with the antigen used in the study is genus-specific rather 
than species·specific [38J. 
Jones et al. used ELiSAs with reticulate bodies of type C and elementary bodies 
of type L2 as antigens in 42 men with NGU. Although there was a good correlation 
between the results of both ELiSAs and the MIF, there was no correlation in this 
group of patients between the presence of anti-chlamydial antibodies and the 
results of culture [39J. Saiku used reticulate bodies of serotype L2 as an antigen in 
the ELISA and also found a good correlation between positive results in this ELISA 
and the MIF [40J. In the studies of Duc-Goiran et al. and Mahony et al. solubilized 
elementary bodies of serotype D and L2 respectively were used as an antigen. In 
both studies a good correlation was observed between the results of ELISA and 
MIF [41,42J. In all the studies mentioned above, the ELISA was found to be rapid, 
more easy to perform than the MIF and was as sensitive as the MIF. A serious 
drawback of these tests is that genus-specific antibodies are detected. Therefore, 
antibodies against C. trachomatis, C psittaci and C. pneumoniae cannot be 
distinguished from each other. Some authors suggested that this test should be 
used as a sensitive first step screening test and if positive, should be followed by a 
specific test to detect chlamydial antigen [27J. However, this option is of little 
practical value in a population with a 11igh background prevalence of anti·chlamydial 
antibodies. 
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Enzyme-Linked Fluorescent Assay 
Theunissen et al. developed an enzyme-linked lIuorescent assay (ELFA) with non-
fixed elementary bodies of C. trachomatis serotypes E, F, H, I, J and LGV 2 as the 
antigens. A good correlation (0.88) was observed between the sensitivity of the 
ELFA and MIF. In contrast to the results of ELISA, cross-reactions between C. 
trachomatis and C. pneumonia were not observed in the ELFA. A major technical 
advantage of this test over the MIF is that the results can be objectively read using 
a Fluoroskan. The use of this test has been advised for epidemiological studies and 
in cases of suspected complicated chlamydial infections such as pelvic 
inflammatory disease (PID) [43J. 
Western Blot Assay 
The Western Blot Assay is mainly of scientific importance for investigating the 
appearance and the persistence of antibodies directed against various chlamydia 
antigens. In this test, sera of high IgG and IgA titres in the peroxidase assay 
reacted with more peptides than those which showed low titres [44J. Wagar et al 
investigated the reaction of sera from women with PID using two 60 kD antigens of 
C. trachomatis. All sera reacted with 57-60 kD M cysteine-rich structural protein of 
the outer membrane complex "amp 2". The other protein, a Triton X-100 soluble 
protein was characterized as the Chlamydia equivalent of a heat shock protein "gro 
EL". Antibodies against this protein were observed in 31% of the women with PID 
and a positive MIF test and in 81% of the women with ectopic pregnancy and a 
positive MIF test. The author suggested that women with PID who have antibodies 
against "gro EL" are the ones who are likely to develop chronic sequela [45J. 
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3.3 LABORATORY TECHNIQUES IN THE DIAGNOSIS OF INFECTIONS WITH 
NEISSERIA GONORRHOEAE 
3.3.1 Anligen dele cling techniques 
Direct identilication of N. gonorrhoeae 
The conventional diagnosis of infection with N. gonorrhoeae is based on the 
presence of intracellular Gram-negative diplococci in smears and in cullure. 
Gram-stained preparations. provided they are evaluated by an experienced 
technician have high sensitivity (83%-96%) and specificity (95%-99%) in men with 
symptoms of urethritis [1.2]. If evaluated by inexperienced technicians, the sensi-
tivity can decrease from 95% to 54% [1). The results of Gram-stained preparations 
in women were poorer [1-4) with a maximum sensitivity of 65% [1). This difference 
could be possibly due to the presence of a larger diversity of the vaginal or cervical 
bacterial flora in which the Gram-negative diplococci are difficult to distinguish. 
Culture of Neisseria gonorrhoeae 
Culturing of N. gonorrhoeae can be performed using selective and non-selective 
culture media. Culturing of N. gonorrhoeae using non-selective media is usually 
difficult to assess because of the overgrowth by other bacteria, especially Proteus 
species. N. gonorrhoeae is mostly cullured using selective cullure media although 
the best results are obtained by using a combination of cultures on selective and 
non-selective media [5]. The original Thayer-Martin selective medium contains 
vancomycin, colistinemethate and nystatin. N. gonorrhoeae grows slowly in this 
medium and the growth of Proteus species is insufficiently suppressed. In the 
modified Thayer-Martin medium more agar and glucose are added and it also 
contains trimethoprim to inhibit the growth of Proteus species [6]. Vancomycin in 
the culture medium is less preferable in regions where many vancomycin-suscep-
tible gonococci occur (sometimes up to 30%) [7). Other selective media are the 
Martin-Lewis medium [8) and the New York City medium [9]. Neisseria colonies can 
be selected by their morphology and colour. The recognition of N. gonorrhoea 
needs further evaluation by sub-culturing and subsequent use of an identification 
test. Conventional sugar fermentation tests and the Rapid Carbohydrate Utilization 
test can be used for identification. Various biochemical identification systems are 
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commercially available [10J. In addilion, immunological identificalion methods 
incorporaling either polyclonal or monoclonal anlibodies are also commercially 
available [11J. 
The culture 01 gonococci, including the identification procedures takes 2 to 4 days. 
The advantage of culturing is that the bacterium is available for auxo-typing and for 
determining susceptibility to antibiolics whereby screening for penicillinase 
producing gonococci (PPNG) and plasmid-induced resistance of gonococci to 
tetracyclines are important. These determinations together with those establishing 
the sort and the size of the plasmids playa very important role in epidemiological 
studies. 
Culture has the best results when the sample from the patient is either directly 
inoculated or is inoculated within 6 hours aller having been transported in a non-
nutrient transport-medium. The sensilivity decreases considerably upon storage for 
longer periods depending on the transport-medium and the temperature. This 
decrease ranged from 4.5% for Stuart medium at 4'C to 79% for Stuart agar at 
room temperature [12J. 
Immunofluorescence 
Direct immunolluorescence on smears of vaginal, cervical and urethral discharge 
using polyclonal antibodies was observed to be expensive, laborious and less 
sensitive than the culture of N. gonorrhoeae. The same was also true for the 
indirect immunolluorescence technique [10,13,14J. The use of monoclonal anli-
bodies against epitopes of protein I in a direct IF test led to a considerable 
improvement in the sensitivity, particularly when used on smears, obtained from 
women. Tesling of duplicate smears prepared at the same time increased the 
sensilivity from 85% to 89% in men and from 72% to 88% in women as compared 
with cullure [15J. 
Antigen delectlon by ELISA methods 
A solid phase enzyme immunoassay which can be used to detecl gonococcal 
anligen in cervical and urethral samples from patients is commercially available 
(Gonozyme, Abbott Diagnostics, USA). Polyclonal anlibodies produced by injecling 
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different strains of N. gonorrhoeae in rabbits are used in this test. Specimen 
obtained from the urethra or endocervix of the patients are applied to the wells of a 
reaction tray. A pretreated polystyrene bead is added to facilitate adsorption of N. 
gonorrhoeae. The anti-gonococcal antibodies are added after removal of the 
unbound antigen. After subsequent washing, horse radish peroxidase-labelled 
sheep anti-rabbit antibodies are added to react with the antigen-antibody complex. 
Following the last washing, each bead is transferred to a 5 ml cuvette and the 
substrate solution containing o-phenylenediamine and H,o, is added. The 
extinction is measured against a substrate blank at 492 nm using a 
spectrophotometer. The Gonozyme test is further evaluated in Chapter 6. 
3.3.2 DNA probes and Polymerase Chain Reaction (PCR) 
In 1983, Totten et al reported a DNA hybridization technique for. demonslraling 
gonococcal DNA in samples oblained from patienls using radio-labelled 2.6 mega 
dalton (mD) gonococcal cryptic plasmid as a probe. Using Ihis lechnique, the 
resulls were positive in 63 of Ihe 71 (89'10) culture-positive men, whereas none of 
Ihe 42 cullure-negative men were positive. Mosl of Ihe false negalive resulls were 
observed with gonococcal slrains of a unique auxolype in which Ihe cryptic plasmid 
was absent [16). In a refined version of Ihis lesl, bolh lile 2.6 mD and Ihe 4.4 mD 
cryptic plasm ids were used as probes. This allowed nol only Ihe delection of 
gonococci, bul also Ihe idenlificalion of Ihe PPNG [17). Panke el al evalualed a 
modilied DNA probe assay (PACE 2, Gen-Probe, San Diego, USA) which required 
only 2 hours 10 investigale 469 cervical samples. In Ihal assay, an acridinium esler-
labelled single-slranded DNA probe complemenlary 10 rRNA of N. gonorrhoeae 
was used. The results in Ihis sludy were compared wilh Ihose of culture using 
samples oblained from 290 asymplomatic pregnant women (gonorrhoeal 
prevalence of 2'10) and 179 symplomatic women (gonorrhoeal prevalence 01 
11.7'10). In the 469 patients, the DNA probe test as compared with culture had a 
sensitivity of 88.9% and a specificity of 100%. The lesl appeared 10 be a suitable 
alternative for culture, especially in situations where the problems 01 transport may 
possibly result in the loss of viable N. gonorrhoeae. Another advanlage is Ihal a 
single sample can be lesled bolh lor N. gonorrhoeae antigen and for C. tracho-
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matis antigen. The test has not yet been evaluated for examining pharyngeal and 
rectal samples or samples from children [18). Can a et al evaluated an assay in 
which a fluorescent oligonucleotide probe from a sequence from the plasmid 
encoded gene cppB was used for detecting N. gonorrhoeae. A total of 119 
reference strains of N. gOllorrhoeae including 8 without plasmids were investigated. 
The results were positive in all strains. One hundred samples from urethra and 
vagina of patients attending the clinic for STD were tested. From these, 31 samples 
were positive and 69 were negative in cullure. All the 31 culture-positive samples 
were also positive in the fluorescent DNA hybridization assay (sensitivity of 100%). 
Three of the 69 culture·negative sampfes were positive in the fluorescent DNA 
hybridization assay (specificity of 95.8%) [19). 
To date, few reports have been published on the use of tile PCR for demonstrating 
N. gOllorrhoeae. In the report by Ho et ai, PCR was compared with culture for 
investigating urethral and cervical samples from men and women. Thirty-four out of 
the 52 samples were positive in cullure. The 34 cullure·positive samples were also 
positive in PCR. An additional 2 samples were observed to be positive in PCR. 
These 2 samples were observed to be positive using the conlirmatory Gonozyme 
test [20). 
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3.3.3 Antibody detecting techniques 
To date several serological tests have been developed for detecting gonorrhoea. 
They comprise the presently obsolete complement lixation test and tests in which 
pili are used as the antigen. 
Complement Fixation Test 
The Complement Fixation Test (CFT) was the lirst serological test to be used. In 
this test, crude anligens prepared from whole cells of one or several gonococcal 
strains were initially used. The test was modified later and was generally used until 
ten years ago [21]. The sensitivity of this test to detect an ongoing infection was 
low: 2·5% for patients with uncomplicated infection and 16-30% for patients with 
complicated infection. Therefore, the test was no longer considered to be of clinical 
value [22]. 
Tests in which pili are used as antigen 
The most successful newer tests are the Indirect Haemagglutination Assay (IHA), 
the Enzyme-Linked Immunosorbent Assay (ELISA) and the Radioimmuno Assay 
(RIA) in which gonococcal pili are used as the antigen. 
Oranje et al compared 3 serological tests for the detection of antibodies against 
gonococci. In the ELISA and the IHA, gonococcal pili were used as the antigen, 
whereas in the complement fixation test (CFT), whole gonococci were used as the 
antigen. In the sera from reconvalescent patients with a culture-proven gonococcal 
infection, the ELISA and the IHA had a sensitivity of 53 % and 54 % respectively in 
women and 41 % and 50 % respectively in men. In these groups the CFT had a 
sensitivity of 22 % and 14 % respectively. The sensitivity of these tests was the 
highest in patients with oropharyngeal gonorrhoea (96 % and 75 %) or with 
complicated gonococcal infections (89 % and 100 %) [23]. 
The indirect haemagglutination test in which gonococcal pili were used as the 
antigen was extensively evaluated by Reiman et al. Among others, they 
investigated 1376 patients for gonorrhoea (from these, 386 were observed to suffer 
from gonorrhoea), 1384 healthy individuals and 54 patients with meningococcal 
infections. The indirect haemagglutination test was observed to have a higher 
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sensitivity than the CFT. Using the CFT, 8 % (men) and 11 % (women) of the 
patients with an ongoing culture-proven gonorrhoea were observed to be 
seropositive, whereas 51% (men) and 88% (women) were observed to be positive 
using the indirect haemagglutination test. They concluded that in the indirect 
haemagglutination test, a non-specific positive test result was rare. The test result 
remained positive in 50% of the culture-negative patients who had suffered from 
gonorrhoea in the past [22J. The same test was used by Duncan et al in a sero-
epidemiological study of gonorrhoea in Ethiopian women. They observed 
gonococcal antibodies in 54% of the women with no clinical evidence of gonococcal 
infection [24J. 
Mietlinen et at. modified the ELISA in which gonococcal pili was used as the 
antigen to investigate the distribution of IgM, IgG and IgA antibodies. The 
determination of the class of antibodies in this test was accompanied by a severe 
loss in sensitivity. Therefore, this did not lead to an improvement of this test for its 
use in clinical diagnosis because of the low overall detection rate [25J. Robertson et 
al used the ELISA with gonococcal pili as the antigen to investigate whether 
infertile women with tuba obstruction had a higher incidence of antibodies against 
gonococcal pili. A very low percentage (2-5%) of the sera from both the test group 
and the control group were observed to be positive lor antibodies against gonococ-
cal pili indicating that gonococci did not play a major role in the etiology of tuba 
obstruction [26J. In 1988, the same authors reported positive results with the same 
test in 32 % of women with ectopiC pregnancy which was significantly higher than 4 
% in women with intrauterine pregnancy. According to the authors the relationship 
between ectopic pregnancy and anti-gonococcal antibodies indicated a role of 
gonococcal infection in the etiology of ectopic pregnancy [27J. 
Western Blot Assay 
The Western Blot Assay has been used thus far mainly to investigate the antibody 
response to gonococcal antigens in an atlempt to delineate those antigens which 
may be suitable for developing a vaccine. 
Aoun et al noted the absence of antibodies against a 70 kD group-specific antigen 
of Neisseria in the sera of patients with a primary or a recurrent gonococcal 
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infection and the presence of these antibodies in the sera of healthy controls who 
never experienced a gonococcal infection. Meningococcal carriage often induces 
anti-70 kD antibodies in children. It was shown that people with first or repeated 
gonococcal infections frequently lack anti-70 kD antibodies. The authors proposed 
the hypothesis that anti-70 kD antibodies could offer protection against N. 
gonorrhoeae [28J. Demarco de Hormache et al described a surface oligosaccharide 
antigen, the so-called epitope C which was the target antigen in bactericidal 
reactions of N. gonorrhoeae by monoclonal antibodies and complement. This 
epitope was present in fresh isolates of N. gonorrhoeae, but absent in strains which 
were repeatedly cultured in vitro. In the western blot, it was observed that 
antibodies against epilope C were present in 80% of the 51 patients with 
gonococcal infections. None of the sera from 271 healthy controls contained 
antibodies against epitope C, although they contained antibodies to other 
lipopolysaccharide (LPS) determinants. The authors concluded that epitope C is 
expressed in vivo in humans and that it is antigenic. The efficacy of epilope C as a 
protective immunogen as suggested by the authors has to be investigated further 
[29J. 
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3.4 LABORATORY TECHNIQUES IN THE DIAGNOSIS OF INFECTIONS WITH 
HERPES SIMPLEX VIRUS 
3.4.1 Anligen detecling techniques 
Dlrecl idenlificalion In patient material 
An infection with herpes simplex virus (HSV) induces several changes in the cell: 
ballooning degeneration, fusion of infected cells into multinucleated giant cells, and 
the formation of intranuclear inclusions. These changes can be visualised in patient 
material after cytological staining as in the Tzanck test. In this test, scrapings from 
the base of vesicles, pustules or erosions are smeared onto a glass slide and air-
dried. The material is fixed in methanol and stained with a cytological stain. The 
staining of the smear is simple and rapid (within minutes) but experience is needed 
for the reading. The test can be used for diagnosis of varicella zostervirus (VZV) or 
HSV, but the two viruses cannot be distinguished from each other. The test can be 
very helpful in situations requiring a rapid answer whether a lesion is herpetic or 
not [1,2J. 
Electron and immuno-electron microscopy can be used for a rapid (within hours) 
identification of herpes virus in suspected lesions. These techniques can be used in 
life-threatening situations as in immuno-compromised patients, neonatal HSV 
infections or neonatal varicella. Using negative staining a sensitivity of 80 % was 
reached. Using colloidal gold immuno-electron microscopy on concentrated virus 
preparations a sensitivity of 95 % was observed [3J. The latter technique allows a 
distinction between HSV and VZV. 
Culture of HSV 
The presence of HSV can be demonstrated by culture on monolayers of cells. 
Various types of cells (I.e. human embryonic lung fibroblasts (Hel), Vera cells and 
Hep-2 cells) have been used to culture HSV. Herpes simplex virus causes a 
characteristic cytopathogenic effect (CPE): swelling and rounding of infected cells 
and formation of polynuclear giant cells (syncitia). The cells die and become 
detached from the surface. These phenomena are characleristic for HSV and 
usually start in several areas of the cell monolayer. The CPE indicates the 
presence of HSV. The speed with which CPE occurs depends on the type of the 
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virus and the type of the host cells that are used. Samples obtained from a herpes 
lesion at an early stage (blisters or ulcers that are less than 4 days old) contain 
more virus particles and are positive more often than samples obtained from 
lesions (ulcers and crustae) that are older than 4 days. With virus-containing 
samples, CPE usually occurs between 2 and 6 days (4). 
The sensitivity of the culture method and the speed of demonstration of HSV were 
improved considerably by centrifuging the samples onto monolayers prior to culture 
and staining the infected cells with labelied-MoAbs against HSV. Using this 
procedure, 65-100% of the positive samples can be identified within 48 hours [5-7). 
Gleaves et al reported that 22 samples out of 98 fresh samples showed CPE after 
6 days using the conventional cullure method. With the centrifugation and MoAb 
staining technique, 23 out of the 98 samples were observed to be positive within 16 
hours after inoculation. This showed that the time required to detect the virus was 
shortened considerably without any reduction in the sensitivity (5). At present, this 
technique is commonly used. The virus can be typed by staining one-half of the 
cover slip with anti-HSV-1 MoAb and the other half with anti-HSV-2 MoAb. 
Other confirmatory methods used to establish the presence of HSV in cultures 
were an ELISA-technique (8) or a fluorescent detection technique with fluorescein-
labelled Helix pomatia lectin (9). 
ELISA methods for the detection of HSV 
One of the first ELISA system that was used to detect HSV antigen in patient 
samples was developed by Land et al. They used commercially available rabbit 
antibodies to HSV-1 (Rlga1) and HSV-2 (Rlga2) in a capture ELISA. The 
antibodies were adsorbed to separate wells of a tray. Samples of patients were 
added. Then, peroxidase-conjugated rabbit antibodies to HSV types 1 and 2 were 
added. After adding the substrate the optical density was measured at 490 nm. The 
assay could be completed within 5 hours. According to the authors, this ELISA 
method allowed the simultaneous detection and typing of HSV antigen (10). The 
capture principle was used in several commercially available ELISA kits: the 
Dakopatt ELISA (Dako, Denmark) [11,12), the Ortho HSV ELISA (Ortho, USA) [12-
14) and the HERPCHEK ELISA (Du Pont Co., USA) [15). Slightly different ELISA 
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systems are the IDEIA (Novo Norddisk) [16,17J and the one developed by Clayton 
[18J. It is not possible to distinguish between HSV-l and HSV-2 infections with the 
latter kits. 
In the Abbott ELISA for HSV detection (Abbott, USA) pretreated polystyrene beads 
are used as the solid phase. This test is evaluated and discussed in Chapter 8. 
3.4.2 DNA detecting methods 
In 1989, Cao et al demonstrated HSV-DNA among DNA extracted from paraffin 
embedded skin biopsies from 7 patients with HSV infections using the polymerase 
chain reaction (PCR). No such DNA was detected among DNA extracted from 3 
normal skin biopsies and 1 herpes zoster lesion [19J. 
The PCR was also tested using samples obtained from the genitalia. Hardy et al 
observed positive results in all 8 samples from which HSV had also been isolated. 
The results of the PCR were also positive in all 4 patients with herpes labialis from 
whom HSV-l had been isolated [20J. Cone et al investigated a total of 4 relapsing 
episodes of herpes genitalis inlections in 3 women. During each episode in these 
patients, daily samples during a period of 10 days were obtained for the PCR and 
the culture. The culture remained positive for an average of 2.6 days, whereas the 
PCR remained positive for an average of 6.8 days. Fifteen out of the 17 samples of 
HSV lesions at the ulcer stage were positive in the PCR, whereas 3 out of the 17 
samples were positive in the culture. From the results of that study, it appeared 
that the PCR was superior to the culture for detecting HSV in tile lesions at an 
advanced stage [21J. Rogers et al investigated a large number of patients with 
herpes genitalis. A total of 79 samples from women undergoing routine examination 
for HSV were tested. The results of both the PCR and the culture were positive in 
32 samples, whereas the results of both were negative in 40 samples. Six samples 
were positive in the PCR, and negative in the culture. One sample was positive in 
the culture, but negative in the PCR. There was no satisfactory explanation for the 
latter observation. However, the results of the PCR using the supernatant from the 
culture of the same sample were positive [22J. 
Piiparinen et al developed a method for detecting and typing HSV simultaneously 
by using a primer pair from the HSV-DNA polymerase coding genes. Using this 
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method, 30 samples out of a total of 31 samples were typed correctly [23J. 
Brice et al demonstrated HSV-ONA in 9 out of the 13 skin biopsies obtained from 
patients with herpes-associated Erythema Exsudativum Multiforme (EEM) and in 6 
out of the 9 patients with idiopathic EEM [24J. Using the peR technique, Miura et al 
demonstrated HSV-ONA in 5 biopsies from skin lesions in patients with relapsed 
HSV infections. In that study, HSV was demonstrated in 5 out of the 8 biopsies 
obtained from patients with HSV-associated EEM [25J. 
The peR was also used in the "non-invasive" diagnosis of HSV-encephalitis to 
detect HSV-ONA in the liquor. Positive results were observed as early as 2 days 
after the onset of neurological symptoms in 9 out of the 10 patients with confirmed 
HSV-encephalitis. The results in all the 12 controls were negative [26J. Similar 
results were also reported in two other studies [27,28J. Aurelius et al used peR for 
extensive investigations into the presence of HSV-ONA in 151 liquors obtained from 
43 patients. The results were positive in 42 patients, whereas the results in all 60 
liquors from controls were negative. The only patient in whom the results were 
negative had received prior therapy. The results in 270 controls, in which liquor was 
replaced by buffer and which were investigated to check for internal contamination 
were negative [29J. Kimura et al used the peR to detect HSV-ONA in samples 
obtained from the mouth, the skin and liquor of 7 neonates with HSV infection. 
Three of the infants had disseminated infections, 2 had infections in the central 
nervous system and 2 had local skin, eye and mouth (SEM) infections. HSV-1 was 
isolated from all but one patient, but in whom like the others, the peR result was 
positive. No false- positive results were observed in the controls [30J. 
At present, commercial kits for routine screening are either unavailable or have not 
yet been sufficienlly evalualed. However, it is expected that such kits would 
become available in the near future. By using a closed system, it appears that the 
initial problems of contamination in the peR have been satisfactorily resolved. 
3.4.3 Antibody detecting methods 
Traditionally, serological techniques have occupied a valuable place in the dia-
gnOSis of HSV infections. The initial test for recognizing anti-HSV antibodies was 
the complement fixation test. Olher tests are neutralization tests and immunoas-
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says like indirect immunofluorescence. Newer tests are the Western Blot Analysis 
(WBA) and the Dot Immunobinding Assay (DIA). However, serological tests are 
mainly used to complement other tests such as virus cultures. In cases in which 
the isolation of the virus is not or no longer possible, HSV infection can only be 
established by means of antibody determination [31-33J. This offers the possibility 
to distinguish between a primary and a recurrent infection, but a distinction 
between HSV-1 or HSV-2 infection is not possible with the traditional serological 
tests for HSV. The distinction between HSV-1 and HSV-2 infection is desirable for 
the following reasons: 
1. For the prognosis: HSV-2 infections often recur genitally, whereas HSV-1 infec-
tions rarely recur genitally [34J. 
2. For epidemiological purposes. 
3. For the screening of HSV-2-positive pregnant women or their partners to identify 
neonates at risk of herpes neonatalis. 
Since there is 50% homology between the genomes of HSV-1 and HSV-2, the 
virions have many determinants which could cause cross-reactions. This hampers 
the development of type-specific immunoassays. Tilerefore, the possibilities to 
demonstrate HSV type-specific antibodies are limited. The most widely used 
methods are based on demonstrating a difference in the neutralizing antibodies 
against HSV-1 and HSV-2. Such tests have fow sensitivity, particularfy if antibodies 
against both HSV types are present. 
Comptement Fixation Test 
The complement fixation test (CFT) is a non-standardized test in which self-
prepared crude antigens are mostly used. In the commercially available CFT, the 
Simplex-2 test (Gene Link, Australia) HSV-2 AG-4 early antigen is used. Under 
optimum laboratory conditions, the sensitivity was 87% and the specificity was 90-
94% for sera collected between 14 and 28 days after the onset of the symptoms 
from patients with a CUlture-proven primary or recurrent infection [35J. However, in 
routine use, the sensitivity and specificity are presumably much lower, but precise 
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data are not available. The eFT is used for demonstrating an increase in HSV an-
tibodies, but the test cannot be used to detect type·specific antibodies [36J. 
Neutralization test 
Neutralizing antibodies are able to inhibit the growth of virus in cultured cells in 
vitro. Such antibodies may be detected by the plaque reduction test or the micro-
neulralization test in which a constant quantity of virus and various concentrations 
of serum are used. The highest dilulion of serum which results in 50% reduction of 
the cytopalhogenic effect is the serum titre in the neutralization assay. 
In the plaque reduction test the monolayer is covered with agar and the virus can 
only spread from cell to cell producing the plaques. The monolayers are stained 
and the plaques are counted macroscopically. The titre is the highest serum dilution 
which produces a 50% reduction in the plaques. This test has been scarcely used 
for HSV-infections. This test has been mainly used to distinguish between HSV-1 
and HSV-2 infections by incubating HSV-1 and HSV-2 cultures with serial dilulions 
of serum from the patients. The titres of the neulralizing antibodies to HSV-1 and 
HSV-2 are used to calculate the Rawl's index which indicates the type of the 
infecting virus [37J. Before the introduction of type·specific tests such as the 
Western blot or tests with glycoprotein G, the neutralizing test was used as the 
standard to evaluate other tests. Of the 220 sera with HSV-2 antibodies in 
Western blot, only 106 (48%) were sero-typed correctly using the micro-neutralizing 
assay [38J. Virus neutralization tests are very laborious and time-consuming. 
Immunoassays 
Immunofluorescent tests are performed on HSV-infected cells fixed to glass slides. 
Antibodies which bind to viral antigens after overlaying the monolayer with serum 
from patients are detected with an anti-igG (or anti-lgM) conjugate. Several tests 
are commercially available. Advantages are the possibility to detect low levels of 
anti-HSV antibodies and the possibility to distinguish between IgM and IgG 
antibodies by the proper choice of the conjugate. The latter possibility allows to 
distinguish between early and recurrent infections. The titres obtained with the 
immunofluorescent tests are similar to those obtained by neutralizing tests [31J. In 
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immunofluorescence tests, both type-common and type-specific antibodies are 
detected. Therefore, these tests cannot be used to distinguish between HSV-f and 
HSV-2 infections [39]. 
Crude viral antigen has been used in a radioimmunoassay (RIA) and a solid phase 
enzyme immunoassay (EIA) [40,41]. Although these tests are more sensitive than 
the micro-neutralization test, they have not been evaluated further. Both tests are 
useless for identifying type-specific antibodies [42]. 
Western Blot Assay 
Extracts of cell cultures which have been infected with HSV-1 or HSV-2 are loaded 
on a polyacrylamide gel. After electrophoresis (SOS-PAGE), the (glyco)proteins are 
transferred to a nitrocellulose membrane (blotting). The membrane is cut into strips, 
which are incubated with the serum of a patient suffering from an HSV infection. 
Antibodies from this serum bind to the antigen(s) of the virus on the nitrocellulose 
strip and are made visible by staining, usually after incubation with an enzyme-
conjugate and the substrate for the enzyme. The serum antibodies react with both 
the structural viral proteins and with virus-induced cellular proteins [43,44]. The 
band pattern that is obtained can be analyzed further using a densitometer [45]. 
For HSV-2, a few type-specific bands can be detected. These bands correspond to 
the polypeptides of glycoprotein G2 (gG2) or its precursors [46-49]. Similar 
polypeptides of glycoprotein G1 (gG1) have been reported for HSV-1 using 
monoclonal antibodies (MoAbs) [50]. The western blot analysis for the detection of 
antibodies to HSV is described in detail in Chapter 8. 
Glycoprotein G 
The HSV-2 type-specific gG2 (92kO) can be purified by affinity chromatography 
using either Helix pomatia lectin columns or columns loaded with anti-gG2 MoAb. 
The HSV-1 type-specific gG1 can be purified only with gG1 MoAb-loaded columns 
[50]. Recently gG1 and gG2 were expressed in recombinant-baculovirus-infected 
insect cells [51] and E.coli [52]_ The type specific glycoproteins G1 and G2 have 
been be used as antigens in various test systems such as EIA or OIA [46,50]. 
These tests are specific, but antibodies against gG appear late in infection. A 
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disadvantage is that the best results are observed with sera obtained from patients 
with recurrent infection or sera taken later than two weeks after the onset of clinical 
symptoms. Tests based on the use of gG2 are described in detail in Chapter 8. 
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CHAPTER 4 
SOLID-PHASE ENZYME IMMUNOASSAY FOR DETECTION OF 
CHLAMYDIA TRACHOMA TIS 

Abstract 
The prototype of a sofid-phase enzyme immunoassay for the detection of Chla-
mydia trachomatis antigen was tested in 403 men and 135 women attending a 
venereaf disease clinic. Culture on HeLa 229 celts was used as reference method. 
In men the overall sensitivity and specility of the enzyme immunoassay was 70% 
and 98.5% respectively. In the 158 men with non-gonococcal urethritis the 
sensitivity and specility was 73% and 96.5% respectively, in the 31 men with post-
gonococcal urethritis 82% and 100%, in the 48 men with gonococcal urethritis 67% 
and 100%, in the 125 men with discharge but normal urinary sediment 54% and 
99.1% and in the 41 men with no signs or symptoms 50% and 100%. 
In women the sensitivity and specility of the assay was 70% and 92% respectively. 
On account of the low degree of sensitivity in both men and women and the low 
degree of specifity in women the prototype of the enzyme immunoassay is not yet 
considered suitable for clinical use. An improved model is being developed. 
Introduction 
Although genital infections causes by Chlamydia trachoma tis seem to occur no less 
frequently than genital gonococcal infections and to give rise to complications as 
frequently, considerably less attention is paid to them. This can partly be attributed 
to the expensive and time-consuming methods required for culture of Chlamydia 
trachomalis [1). Recently, two rapid methods based on antigen detection were 
developed for the diagnosis of Chlamydia trachomalis infection. One method uses 
lIuorescein-labelied monoclonal antibodies against Chlamydia trachomalis. The 
other method, a solid-phase enzyme immunoassay, is similar to an enzyme 
immunoassay devefoped for detection of gonococcal antigen [2-5) but in contrast to 
the latter assay has not yet been evaluated extensively. In a recent study an 
enzyme immunoassay was used to detect Chlamydia trachomatis infection in men 
and women attending a venereal disease clinic [6). 
This study presents the results obtained with the prototype of a solid-phase enzyme 
immunoassay for the detection of non-complicated urethral infections in men and 
ceNical infections in women caused by Chlamydia trachoma tis, using conventional 
cell culture as reference method. 
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Materials and Methods 
Patients. 01 the 403 men examined 158 were suHering 10m non-gonococcal 
urethritis, 31 Irom post-gonococcal urethritis and 48 from gonococcal urethrisi. The 
criterion for diagnosis of urethritis was tile presence of more than 10 leu co-
cytes/field (magnification 250 x) in the sediment of tile first 10-15 ml of urine 
collected when the patient had not voided for 4h or longer. The presence of 
discharge in 125 men without this increase in leucocyte count was not regarded as 
urethritis, however no early morning smears were perlormed in these men. Forty-
one men had no signs or symptoms at all. The 135 women examined were 
screened regularly for sexually transmissible diseases at an outpatient clinic. 
Samples. In men tile samples were taken from the urethra and in women from the 
endocervix. All samples were collected between November 1983 and June 1984. 
Samples were taken for the following: culture for Neisseria gonorrhoeae, 
gramstained smear (if possible), culture for Chlamydia trachomatis, and the 
enzyme immumnoassay. The samples for the culture were taken with the aid of a 
metal-shafted cottonwool-tipped swab moistened in 0.2 M sucrose phosphate buHer 
containing 25 ~g/ml gentamicin and 2.5 ~g/ml amphotericin. The swab was inserted 
into the urethra in men and the endocervix in women, rotated for a few seconds 
then replaced in 2 sucrose phosphate (2 SP) transport medium. The samples were 
stored in liquid nitrogen until processed. Plastic-shafted cotlonwool-tipped swabs 
were used for collection of samples for the enzyme immunoassay, as 
recommended by the manufacturer. The swabs were placed in a tube with 1 00 ~I 
of storage buHer (Abbotl). The tubes were kept at 4° C and processed within three 
days. 
Culture. Chlamydiae were cultured on mono layers of HeLa 229 cells seeded on 
coverslips in flat-botlom tubes. The full-grown monolayer was pre rinsed with 30 
~g/ml DEAE dextran in Hank's balanced salt solution. Then, 250 ml of the carefully 
vortexed sample was added to two flat-botlom tubes and centrifuged for 1 h at 
2700 X g. After drawing oH the sample material the tubes were incubated for three 
days at 37° C with complete glucose medium containing 25 ~g/ml gentamicin, 25 
~g/ml vancomycin and 2.5 ~g/ml amphotericin. After fixation and Giemsa staining 
the coverslips were screened for inclusion bodies using darkfield illumination at a 
86 
magnification of 250 times. The flat-bottom tubes for subpassage were 
subsequenlly sonicated at a frequency of 10kHz for 10 sec and 250 ~t of the 
materiats was transferred to a fresh monolayer. Cultures were considered positive if 
one or more inclusions were observed in primary or passaged monolayers. 
Solid-Phase Enzyme immunoassay. The assay was a non-marketed research 
prototype for detection of Chlamydia trachomatis antigen. One mt of dilution buffer 
(Abbott) was added to the tube with the sample. After incubation for 10 min at 
room temperatuse the contents of tile tubes were carefully mixed on the Vortex in 
three cyctes of 15 sec. The liquid was expressed from the swabs by rotating and 
pressing the tip of the swab against the wall of the tube. Sample materiat (200 ~I) 
was introduced into the wells of plastic plates. One positive and three negative 
controls were tested simultaneously. A bead, pretreated to permit absorption of 
Chlamydia trachoma tis antigen on the surface, was added to each well. The wells 
were covered with adhesive seals, and the plates incubated for 45 min in an 37' C 
water bath. After a washing procedure which consisted of three rinSings with 
distilled water using a pentawasher (Abbott), 200 ~I of antibody preparation (rabbit) 
and then 200 ~I of conjugate (goat horseradish peroxidase conjugated antibody to 
rabbit immunoglobulin G) were added. Each step was followed by incubation and 
the washing procedure described abbove. The beads were then transferred to 5 ml 
cuvetles, 300 ~I of substrate (orthopenylene diamine with H,O,) added, and the 
cuvetles incubated for 30 min at room temperature. The reaction was stopped by 
adding 1 ml of N H,SO,. This resulted in a yellow colour change in samples 
containing Cillamydia trachomatis antigen. After mixing, the colour intensity was 
read at 492 nm on a Quantum spectrophotometric analyzer against a substrate 
blank. Test results with an extinction value of 0.100 00 plus the average of 
negative controls were regarded as positive. 
Statistical Analysis. The sensitivity, specifity and predictive value of a positive and 
negative test result were calculated by tile method of Vecellio 17). The results of 
the enzyme immunoassay were compared with the combined results of culture and 
subculture. 
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Results. 
The results of the enzyme immunoassay and culture are shown in Table 1. In men 
both tests were positive in 53 of 403 patients; culture only was positive in 23 
patients and enzyme immunoassay only in five patients. When the men were 
divided into groups according to symptoms and signs, the number of positive 
results obtained by culture was consistently higher tilan that obtained by enzyme 
immunoassay, although in some categories too few specimens were tested to 
make lirm conclusions. In women both tests were positive in 16 of 135 
Tabte1: Detection of Chlamydia trachomatis by enzyme immunoassay and culture 
in various patient groups. 
Assay + Assay - Assay + Assay -
Patient group N Culture + Culture + Culture - Culture -
Men 
Non-gonococal 
urethritis 158 32 12 4 110 
Post-gonococcal 
urethritis 31 9 2 0 20 
Gonococcal 
urethritis 48 4 2 0 42 
Discharge, no ab-
normalities in 
sediment 125 7 6 1 111 
No signs or symp-
toms 41 1 1 0 39 
Total men 403 53 23 5 322 
Women 135 16 7 9 103 
cervical samples; culture only was positive in seven women and enzyme immu-
noassay only in nine. 
The prevalence of a positive Chlamydia trachomatis culture, the sensitivity, specifity 
and predictive value of a positive and negative result of the enzyme immunoassay 
versus culture and subculture are given in Table 2. The sensitivity of the enzyme 
immunoassay was 70% in both men and women, and ranged from 50% to 82% in 
tile various groups of men, with large 95% conlidence 
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Table 2: Prevalence of a positive Chlamydia trachomatis culture, sensitivity, 
specifity and predictive value of a positive and negative result of the enzyme 
immunoassay versus culture and subculture in various patient groups (95% confi-
dence limits in parenthesis). 
Patient N Prevo Sensi Speci- PPV NPV 
group pas. tivity ficity (%) (%) 
cult. (%) (%) 
(%) 
Men 
Non-gono- 158 27.9 73 96.5 89 88.7 
coccal uret- (21.0- (57.2- (91.3- (73.9- (83.5-
hritis 35.5) 85.0) 99.0) 96.6) 94.8) 
Post-go no- 31 35.5 82 100 100 91 
coccal uret- (19.2- (48.2- (83.2- (66.4- (70.8-
hritis 54.6) 97.7) 100) 100) 98.9) 
Gonococcal 48 12.5 67 100 100 96 
ure- (4.7- (22.3- (91.6- (39.8- (84.5-
thritis 25.3) 95.7) 100) 100) 99.4) 
Discharge, 125 10.4 54 99.1 88 94.4 
no abnor- (5.7- (25.1- (95.3- (48.2- (89.2-
malities in 17.1 ) 80.8) 100) 99.7) 98.1) 
sediment 
No signs or 41 4.9 50 100 100 98 
symptoms (0.6- ( 1.4- (91.0- ( 0- (87.3-
16.5) 98.7) 100) 100) 99.9) 
Total men 403 18.9 70 98.5 91 93.6 
(15.2- (58.1- (96.6- (81.0- (90.4-
23.0) 79.8) 99.5 97.1) 95.9) 
Women 135 17.0 70 92.1 64 93.6 
(11.1- (47.4- (85.3- (42.5- (87.3-
24.5) 86.8) 96.3) 82.0) 97.4) 
intervals. The highest sensitivity was reached in groups with the 11ighest prevalence 
of positive cultures. 
The overall specifity was 98.5% in men and 92% in women. In men the specifity in 
the various groups varied from 96.5% to 100%. The lowest value was observed in 
men with non-specific urethritis. The predictive value of a positive enzyme immu-
noassay result was notably low in women. 
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Discussion 
The sensitivity of the enzyme immunoassay in the various groups of men with 
signs and symptoms of urethritis varied from 67% to 82%. The specifity in these 
groups varied from 96.5% to 100%. In women the sensitivity and specifity was 70% 
and 92.1 % respectively. Using the same test Jones et al. [6] found a sensitivity of 
81 % and a specifity of 98% in a group of men and women with urethritis and 
cervicitis. 
The ranges of the 95% confidence limit in Table 2 are large. To narrow these 
ranges more positive patients would have to be examined. The prevalence of a 
positive Chlamydia trachomatis culture in male patients suffering from non-specific 
ure!llritis, gonococcal urethritis and in particular post-gonococcal urethritis was 
rather low (Table 2) but does not differ from previous findings in similar patients 
(unpublished data). 
The sensitivity of the enzyme immunoassay for detection of Chlamydia trachomatis 
was lower than that of an enzyme immunoassay for detection of gonococcal 
antigen [2-5] which is already used routinely. In women the specifity of the enzyme 
immunoassay for Chlamydia trachoma tis was much lower than the specifity of the 
enzyme immunoassay for Neisseria gonorrheae. Apart from an enzyme 
immunoassay which detects antigen, immunofluorescence tests with labelled 
monoclonal antibodies can also be used for rapid diagnosis of chlamydial 
infections. With the latter method Tam et al. [8] obtained a sensitivity of 93% and a 
specifity of 96% using culture on McCoy cells as reference method. In our 
experience, however, this test involves highly monotonous work for laboratory staff 
in a dark room. Provided an enzyme immunoassay with a higher sensitivity and -
notably for women- a higher specifity can be developed, it would be preferable to 
an immunolluorescence test as it permits the screening of large numbers of 
samples. 
An improved model of the enzyme immunoassay is at present under evaluation. 
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CHAPTER 5 
EXPERIENCE WITH A SOLID PHASE ENZYME IMMUNOASSAY 
FOR THE DETECTION OF NON·COMPLICATED CERVICAL 
INFECTION IN WOMEN CAUSED BY 
CHLAMYDIA TRACHOMA TIS. 

Abstract 
To evaluate the usefulness of a solid phase enzyme immmunoassay for diagnosis 
of cervical chlamydial infections, samples of 246 women were tested using the 
assay and cell cultures. Tile overall sensitivity of the assay was 67% and specility 
was 92.4%. 
When the patients were classified into groups according to the semiquanlitative 
leucocyte score (0-4) the highest prevalence of Chlamydia-positive culture (21.3%) 
and the highest sensitivity (77%) were found in patients with score 3-4. The mean 
absorbance in the assay was higher, and a higher percentage strong positive 
cultures was found in culture positive samples of patients with leucocyte score 3-4. 
The sensitivity of the immunoassay was 54% in samples with chlamydial culture 
with less than 20 inclusions per slide. Therefore this enzyme immunoassay failed to 
detect chlamydial infections in nearly the half of the patients with a low load of 
chlamydial antigen. 
Introduction 
During IIle past decade more attention has been paid to genital infeclions caused 
by Chlamydia trachomatis. In women the uncomplicated chlamydial genital 
infections can occur without any symptoms but the sequelae may be serious; 
endometritis, acute or chronic salpangitis, and perihepatitis. Salpingitis is associ-
ated with an increased risk of infertility and ectopic pregnancy due to post-
infections damage to the fallopian tubes [1J. 
Genital infections due to Chlamydia trachomatis can cause major diagnostic 
problems. Most physicians have no facilities to culture Chlamydia trachomatis. The 
culture methods also have some serious disadvantages such as being laborious, 
expensive and time consuming. Technical problems in transportation and in culture 
methods can lead to false negative results. Men willl symptoms of non-specific 
urethritis can be treated effectively with antibiotics against Chlamydia trachomatis. 
But in women usually with none of only subtle clinical manifestations, the diagnosis 
of chlamydial infection is more difficult [2,31. 
Rapid diagnostic test which detect chlamydial antigens without the need to culture 
the organism may provide an effective tool for the early detection and subsequent 
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control of genital infections caused by Chlamydia trachomalis and to prevent 
complications by this microorganism. In the past, a rapid method using fluoresceine 
tabelled monoclonal antibodies was introduced to identify Chlamydia trachomalis 
etementary bodies in genitat smears [4-6J. A second rapid method for detection 
Chlamydia trachomalis antigen is a solid phase enzyme immunoassay [7-11J. In 
this study 246 women attending the University Hospital's venereology outpatient 
department were screened for Chlamydia trachomalis infection using two different 
methods. The results obtained using a rapid solid phase enzyme immunoassay [7-
11J were compared to those obtained using a conventionat cell culture technique. 
Materials and Methods 
Patients. Two hundred and forty six women, visiting the outpatient department for 
sexually transmissible diseases were examined. Cervical samples were collected 
from symptomatic as well as asymptomatic patients and from female contacts of 
males with non-specific urelhritis. Patienls were classified in various groups as 
follows: a. the semiquantative leucocyte number in the Gramstained cervical smear; 
b. age, and c. the outcome of the gonococcal culture. 
Samptes. In addition to the samples from the cervix for Neisseria gonorrhoeae 
culture and a Gram-stain smear, two separate samptes were collected. The first 
was used to culture Chlamydia trachoma tis and the second was used to perform 
the solid-phase enzyme immunoassay. The samples for the culture were taken 
after cleaning the portio from superfluous mucous with a metal shafted cottonwool-
tipped swab. The swab was rotated in the endocervix for severat seconds and then 
placed in a vial containing 2.0 ml of 0.2 M sucrose phosphate buffer (2 SP) 
containing 25 ~giml gentamicin and 2.5 ~giml amphotericin. The samples were 
stored in liquid nitrogen until processed. Plastic shaft swabs as recommended by 
the supplier (Abbott, USA) were used to obtain samples for the solid-phase enzyme 
immunoassay using the same technique and placed in a tube containing 0.1 ml 
specimen storage reagent (Abbott). All specimen were stored at 4° C and 
processed within 72 hours. 
Cell-culture. Samples for culture were mixed on a Vortex mixer and 250 ~I of the 
diluted sample was inocutated into duplicate ffat bottom tubes containing DEAE 
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dextran pretreated fult grown HeLa 229 monolayers on covers lips. The tubes were 
centrifuged for one hour at 2700 x g. After three days incubation at 37' Cone 
coverslip was fixed and stained according to Giemsa. The whole coverslip was 
examined for inclusion bodies using darkfield illumination. Covers lips containing at 
least one inclusion were considerd to be positive. If more than 20 inclusions were 
observed in the coverlips of the first passage, the culture was considered to be 
strongly positive. To perform a second passage the duplicate culture was sonicated 
and 250 ~I of the diluted sample was inoculated onto a fresh monolayer. 
Solid Phase Enzyme Immmunoassay. The assay was an experimental research 
prototype for the detection of Chlamydia trachomatis antigen (Abbott). Prior to the 
assay 1 ml Chfamydiazyme specimen dilution buffer (Abbott) was added to each 
tube containing a swab with patient material. After incubation for 10 minutes at 
room temperature the tube was mixed on a Vortex mixer for three cycles of 15 
seconds. The swab was rotated and pressed against the walt of the tube to 
squeeze out the excess fluid which was discarded. Two hundred microliter of 
sample material, positive and negative controls, were plated into the welts of a 
plastic tray. To each welt, a bead was then added and the tray was incubated for 
45 minutes in a waterbath at 37°C. After rinsing 200 ~I of an polyclonal rabbit anti-
chlamydia-antibody preparation was added to each welt. After incubation for 45 
minutes at 37"C and rinsing, 200 ~I of goat horseradish peroxidase-conjugated 
antibody immunoglobulin G was added. After incubation for 45 minutes at 37"C 
foltowed by rinsing, the beads were transferred to 5 ml cuvettes. The reaction was 
developed by the addition of 300 ~I of the substrate (Orthophenylene diamine with 
H,02)' After incubation at room temperature for 30 minutes, the reaction was 
stopped by the additon of 1 ml of N H2S04, The absorbance was read at 492 nm on 
a Quantum spectrophotometer (Abbott). The cut-off point of a positive test was set 
at an optical density (OD) of 0.100 plus the mean absorbance observed in the 
three negative controls. 
Statistical analysis. The Fisher's exact test and the Mann Whitney U test are used 
to determine statistical significance. 
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Results 
Wilen the patients were classified into groups according to the semi-quantative 
leucocyte score (0-4) in the Gram stained celVical smear, the concordant and 
discordant results between enzyme immunoassay and culture are shown in Table 
1. The results of both detection methods were positive in 24 of the 246 patients. 
Culture was exclusively positive in 12 patients, enzyme immunoassay in 16 
patients. 
Table 1. The detection of Chlamydia trachomatis by enzyme immunoassay and cell 
culture and results of gonococcal culture in relation to leucocyte score. 
Assay 
Leuco- pas. 
cyte Culture 
score" N pas. 
0 26 2 
1 82 5 
2 77 7 
3 48 6 
4 13 4 
Overall 246 24 
results 
• 0 = no leucocytes per lield 
1 = 1-5 leucocytes per lield 
2 = 6-10 leucocytes per lield 
3 = 11-20 leucocytes per lield 
4 = >20 leucocytes per lield 
Assay 
pas. 
Culture 
neg. 
3 
5 
3 
4 
1 
16 
C. trachomatis N.go-
norrh. 
Assay Assay Culture 
neg. neg. pas. 
Culture Culture 
pas. neg. 
2 19 0 
3 69 3 
4 63 8 
3 35 11 
0 8 3 
12 194 25 
The prevalences of positive chlamydial and gonococcal cultures are shown in Table 
2. For these subgroups the sensitivity and the specifity of the enzyme 
immunoassay versus culture and subculture expressed in percentages are also 
shown in Table 2. 
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In patients with a relatively low leucocyte number (0-2) in the Gram stained smear, 
the prevalence 01 a chlamydia-positive culture was 12.4% and the 
prevalence of a positive gonococcal culture was 6%. In this group the sensitivity 
Table 2. The prevalence of positive cultures for Chlamydia trachomatis and Neisse-
ria gonorrhoeae, and the sensitivity and the specifity of the enzyme immunoassay 
as compared to cell culture of Chlamydia trachomatis. 
Prevalence pos. culture EIA C. trachomatis 
Leucocyte C. trachoma- N. gonor- sensitivity specifity 
score tis rhoeae (%) (%) 
(%) (%) 
0 lS.4 0 SO 86.4 
1 9.8 3.7 62.S 93.2 
2 14.3 10.4 63.6 9S.S 
3 18.8 22.9 66.7 89.7 
4 30.8 23.1 100 88.9 
Overall result 14.6 10.2 67 92.4 
of the enzyme immunoassay as compared to culture was 61 %. 
In cUlture-positive patients with a leucocyte score of 0-2, the percentage of strongly 
positive cultures was 21.7. The mean absorbance in the enzyme immunoassay was 
0.344. 
In patients with a relatively high leucocyte number (3-4), the prevalence of a 
chlamydial positive culture was 21.3% (not Significant). The prevalence of a positive 
gonococcal culture was 23% (significant, P = 0.004). The sensitivity of the assay 
was 77% (not significant) for this group. 
In cUlture-positive patients with a leucocyte score of 3-4, the percentage of strongly 
positive cultures was 38.S% (not significant). The mean absorbance in the enzyme 
immunoassay was 1.144 (significant, P = 0.183). 
In patients who were positive for Neisseria gonorrhoeae culture, the prevalence of 
a positive chlamydial culture was 24% (Table 3). In this group the sensitivity 
of the enzyme immunoassay as compared to cell culture was SO% and the specifity 
was 84.2%. 
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Table 3. Results of culture for C.trachomatis and sensitivity and specility 01 the 
enzyme immunoassay versus culture in patients with positive of negative culture lor 
N.gonorrhoeae. 
Culture lor C. trachomatis 
N. gonorrhoeae 
results of culture results 01 assay 
prevalence sensitivity specility 
% (no.) % (no.) % (no.) 
Positive 24 50 84.2 
(6/25) (3/6) (16/18) 
Negative 13.6 70 93.2 
(30/221 ) (21/30) (178/191 ) 
In patients with a negative culture for Neisseria gonorrhoeae the prevalence 01 a 
chlamydia-positive culture was 13.6%, the sensitivity was 70% and the specifity 
was 93.2%. 
In Table 4 the relationship between age and the prevalence of Chlamydia tra-
chomatis and Neisseria gonorrhoeae is shown. In the younger age group (S: 25 
years) the prevalence of C/Jiamydia trachomatis was much higher (24.2%) as 
compared to the prevalence of Neisseria gonorrhoeae (13.7%). For both Chlamydia 
trachomatis and Neisseria gonorrhoeae, the highest prevalences were obselVed in 
the younger age groups. There was little difference in the sensitivity and specifity 01 
the enzyme immunoassay in the two age groups. 
Table 4. Prevalence 01 positive cultures for C.trachomatis and N.gonorrhoeae and 
results of the enzyme immunoassay in two age groups. 
Prevalence Results assay versus 
Age culture 
group 
N.gonorrhoeae C.trachomatis sensitivity specility (years) N % (no.) % (no.) % (no.) % (no.) 
<25 95 13.7 24.2 69.6 91.7 
(13/95) (23/95) (16/23) (66/72) 
>25 151 7.9 8.6 61.5 92.8 
(121151) (13/151) (8/13) (128/138) 
In six patients a mucopurulent celVical discharge was obselVed. Of these patients 
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one was positive both for chlamydial and gonococcal culture. 
Of the nine known contacts of males with nonspecific urethritis two (22%) were 
positive for culture of Neisseria gOllorrhoeae and three (33%) for Chlamydia 
trachomatis. 
Twenty-six patients had less than 20 inclusions in the first slide of the Chlamydia 
trachomatis-culture. Fourteen of these 26 (54%) were positive in the enzyme 
immunoassay. Ten patients had a strong positive culture for Chlamydia trachomatis 
(more than 20 inclusions in the coverslip of the first passage). All of them (100%) 
were positive in the solid phase immunoassay. This difference was statistically 
significant (P = 0.02). 
Discussion 
In this study the overall sensitivity of the solid phase enzyme immunoassay as 
compared to cell culture was 67% and specifiticy was 92.4% with a prevalence of 
14.6%. 
Using the same immunoassay Jones et al (7) observed a sensitivity of 81 % and a 
specifity of 98% in a group of men and women with urethritis and cervicitis. 
Moi (9) observed a sensitivity of 86.3% and a specifity of 94.7% for the Chla-
mydiazyme in males. Pathier (1)) observed in 417 specimens from females with a 
low disease prevalence (8.1%) a sensitivity of 91.2% and a specifity of 96.6% as 
compared to cell culture. Cultures in all three studies were stained with iodine. In a 
previous study (11) the highest prevalences (12.5 - 27.9%) and the highest 
sensitivities (67-82%) for this enzyme immunoassay were observed in men with 
urethritis (more than 10 leucocytes in the sediment of the first voided urine). In men 
without urethritis, the prevalence varied from 4.9 to 10.4% and the sensitivities from 
50 to 54%. 
When the results of this study were classified into the semiquantative leucocyte 
score in the Gram-stained cervical smears, the highest prevalences (18.8% -
30.8%) and the highest sensitivities (66.7 - 100%) were observed in women with a 
leucocyte score of 3 to 4. These groups also showed the highest numbers of 
strong positive cultures (38%) and the highest mean absorbance (1.144) in the 
immunoassay. These results suggest that the antigen load in patients with 
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leucocyte score of 3 to 4 is higher than that in patients with leucocyte score of 0 to 
2. 
When the patients were classified in subgroups according to the outcome of the 
gonococcal culture, or according to their age, variations in the prevalence of 
Chlamydia positive culture were found but no clear relationship between the preva-
lence and the sensitivity was observed. 
In the patients with strongly positive chlamydial cultures (;' 20 inclusions per slide), 
the sensitivity of the enzyme immunoassay was 100%. In patients with chlamydial 
cultures with less than 20 inclusions per slide, the sensitivity of the enzyme 
immunoassay was 54%. Therefore the enzyme immunoassay failed to detect 
chlamydial infections in nearly half of the patients with a low load of chlamydial 
antigen. 
For the evaluation of a new diagnostic technique it is extremely important to have 
also samples of patients with less than severe chlamydial infection. Selection 
criteria of patients can have influence on the sensitivity of this enzyme immunoas-
say. This variation ranged from 50% to 100% in the present study. Modification in 
enzyme immunoassay of cell culture can further influence the outcome of these 
comparative studies. 
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CHAPTER 6 
EXPERIENCE WITH A MODIFIED SOLlD·PHASE ENZYME 
IMMUNOASSAY FOR DETECTION OF GONORRHOEA 
IN PROSTITUTES 

Abstract 
The modified Gonozyme Test (Abbott Laboratories; Chicago, IL), a new enzyme 
immunoassay for detection of Neisseria gonorrhoeae, was evaluated in testing of 
266 prostitutes. When the enzyme immunoassay was used with material from the 
cervix, the prevalence of gonorrhoea was 8.4%. As compared with culture results, 
this rate represents a sensitivity of 88% and a specifity of 99.2%. A sensitivity of 
71 % and a specifity 98.9% were registered for tests of urethral material. In a 
comparison of the two tests without accepting either one as standard, the 
sensitivity of the enzyme immunoassay was 90% for material from the cervix and 
the specifity was 100%. There are several possible causes for discordance 
between results of culture and of enzyme immunoassay. The high predictive value 
of a negative enzyme immunoassay in screening urogenital samples from pros-
titutes makes this test very suitable for rapid elimination of gonorrhoea from this 
pool of patients. 
Introduction 
Women are normally screened for gonorrhoea by making a Gram stain of material 
from the cervix and uretllfa and a culture of material from the cervix, urethra, 
rectum and tonsils. The Gram stain has the advantage that the outcome is 
available very quickly. It is also specific, but its sensitivity, at best, is 65% (1 J. A 
culture is much more sensitive and more specific but has tile disadvantage that the 
result is not available for at least 48 hr; this incubation time means a fairly long 
interval between the first visit and treatment of the patient. For prostitutes in 
particular, there is a need for rapid, sensitive, and specific test for gonorrhoea. 
A previous publication [2J reported on the use of a solid-phase enzyme immu-
noassay (EIA) in a study of the prevalence of Neisseria gonorrhoeae antigen in 
various groups of patients atlending a sexually transmitled diseases (STD) clinic. 
When the test was used with a group of 102 prostitutes, its sensitivity and specifity 
appeared to be satisfactory. Due to the limited number of positive results, however, 
tile range of the 95% confidence interval was rather large. In order to determine 
more precisely, the diagnostic value of both the EIA and culture was studied in a 
larger group of prostitutes. The importance of the EIA as an aid in detecting 
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sources of gonorrhoea among prostitutes is discussed on the basis of the results 
obtained. 
Patients and Methods 
Patients examined 
A group of 266 prostitutes attending the outpatient clinic submitted to examinations 
every two weeks. A total of 572 examinations were performed during a three month 
period in 1983. The birlhdate of all patients was recorded. 
Collection of Specimens 
Specimens were collected from the urethra and endocervix. Sampling material from 
the cervix was done with two cotton wool-tipped plastic swabs. One swab was used 
for EIA and one for culture. To obtain cervical material, mucus was removed from 
the cervix, and the swabs were rotated for several seconds in the endocervix. The 
swabs were then removed, and care was taken to avoid contact with the vaginal 
wall. Sampling of material from the urethra was done by use of two cotton wool-
tipped plastic swabs, one for the EIA and one for culture. The sampling sequence 
of urethral and clinical specimens for EIA and culture was in accord with a list of 
random numbers. 
The swabs used for EIA were immersed in 0.2 ml of specimen storage agent 
(Abbott Diagnostic Products GmbH, Wiesbaden, West Germany) and stored at 4 °c 
for a period not exceeding five days. According to the manufacturer, results of the 
EIA are still reliable if the test is performed within this period. 
Culture Procedure 
The swab used for obtaining the culture specimen was immediately inoculated onto 
modified Thayer-Martin medium and onto chocolate agar. The plates were 
incubated at 37°C for two days in an atmosphere containing 3-5% CO,. Gonococci 
were identified by gram-staining and by sugar fermentation tests. 
Assay Procedure-
The Gonozyme diagnostic kit contains the following reagents: polystyrene beads 
pretreated to facilitate adsorption of N.gonorrhoeae antigen; antibodies to 
N.gonorrhoeae obtained by injecting gonococcal strains into rabbits, the diversity of 
the antibodies having been extended since the previous study [2) by injecting also 
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antigens from gonococcaf slrains isolated from patienls wilh false-negalive resulls 
in the Gonozyme lesl, the firsl prololype of Ihis test; a goat anli-rabbit IgG 
horseradish conjugale; a positive and a negative conlrol; specimen storage 
solution; and specimen dilution buffer (Abboll). The substrale in Ihe enzyme 
immunoassay was o-phenylenediamine, plus H,02' 
Before assay 1 ml of dilution buffer (Abboll) was added 10 Ihe lube containing Ihe 
swab wilh the clinical male rial. After 2-5 min Ihe swab was shaken vigorously on a 
vorlex mixer for 15 sec, expressed, rotated against the wall of the lube in order to 
remove excess lIuid, and discarded. The beads were immersed in 0.2 ml of Ihe 
suspension in the wells of a Iray. After immersion of the beads the Iray was 
covered wilh an adhesive seal and incubaled for 45 min in a walerbalh (37 °C)_ For 
removal of unadsorbed malerial, the beads were then washed Ihree times in a lotal 
volume of 15 ml of dislilled waler with an Abboll Penlawasher II. Nexl, 0.2 ml of 
anlibody 10 N.gonorrhoeae and 0.2 ml of antibody-enzyme conjugate were added 
consecutively to each well. Each step was followed by incubation of the tray and 
washing as indicated. After the last washing each bead was transferred to a 5 ml 
cuvelle, and 0.3 ml of freshly prepared substrate was added. After incubation for 
30 min at room temperature (22°C), the enzyme reaction was stopped by addition 
of 1 ml of 1 N HCI; the extinction was measured against a subslrate blank on a 
Quantum spectrophotometric analyzer (at 492 nm)_ The cut-off point of a positive 
test was set at an 00 of 0.19 plus the mean extinction observed for three negative 
controls. 
Statistical Method 
The X' method for independent samples was used for determination of the level of 
significance. Sensitivities, specifities, and predictive values were calculated 
according to the method of Vecchio [3J. In addition, the approach described by Hui 
and Walter [4) was applied for estimation of the sensitivities and specifities of both 
tests (EIA and culture) simultaneously without accepting either as standard. Tilis 
method was applied to cervical samples only. It required division of the subjects 
into two subgroups according to objective criteria (age). 
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Results 
Concordant and discordant results between culture and EIA are shown in Table 1. 
Discordant results between culture and EIA were observed more often among 
urethral than among cervical samples. 
Table 1. Numbers of specimens with concordant and discordant results between 
culture and Enzyme Immunoassay (EIA) for cervical, urethral, and cervical 
andlor urethral specimens. 
Result Cervix Urelhra Cervix andlor Urethra 
Culture +, EIA + 44 25 47 
Culture -, EIA + 4 6 6 
Culture +, EIA - 6 10 6 
Culture -, EIA - 518 531 513 
The prevalence of positive cultures as well as the sensitivities, specifities, and the 
predictive values of the EIA as compared with culture for specimens of various 
origin are shown in Table 2. The prevalence of positive cultures was lower for the 
urethral (6.1%) than for the cervical specimens (8.7%). The sensitivity of the 
Table 2. Prevalences of positive cultures, sensitivities en specifities of Enzyme 
Immunoassay (EIA) vs. culture, and predictive values of positive and negative EIA. 
Percentage (95 % Confidence Limits) 
Measurement Cervix Urethra CerviX/Urethra 
Prevalence of 8.7 (6.6-11.4) 6.1 (4.3-8.4) 9.3 (7.0-11.9) 
positive culture 
Sensitivity of EIA 88 (76-95) 71 (54-85) 89 (77-96) 
Specificity of EIA 99.2 (98.1-99.8) 98.9 (97.6-99.6) 98.8 (97.5-99.6) 
Predictive value 92 (80-98) 81 (63-93) 89 (77-96) 
of positive EIA 
Predictive value 98.9 (97.5-99.6) 98.2 (96.6-99.1) 98.8 (97.5-99.6) 
of negative EIA 
EIA for cervical samples was 88% (95% confidence limits, 76-95%); the specifity 
was 99.2% (95% confidence limits, 98.1-99.8%). The corresponding figures for 
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urethrat samples were 71% (54-85%) and 98.9% (97.6-99.6%). The figures 
obtained when the results lor cervical and urethral samples are combined hardly 
differ fom the results with cervical specimens alone. 
For assessment of the sensitivities and specifities of EIA and culture without 
accepting either as standard (4), women were divided into two groups on the basis 
of age; one group was born between 1928 and 1955 (group 1), and the other was 
born between 1956 and 1967 (group 2). Concordant and discordant results 
between culture and EIA for cervical specimens for women of these age groups are 
shown in Table 3. 
Table 3. Concordant and discordant results between culture and Enzyme 
Immunoassay (EIA) of cervical specimens from two age groups. 
Result Group 1 ' 
Culture +, EIA + 13 
Culture - , EIA + 1 
Culture +, EIA - 2 
Culture - , EIA - 254 
'Women born between 1928 and 1955 
'Women born between 1956 and 1967 
No. of specimens 
Group 2 ' 
31 
3 
4 
264 
As shown in Table 4, the prevalence of a positive culture among patients from 
group 1 (5.6%) was about half the prevalence among patients from group 2 
(11.6%). No significant differences in sensitivity and specifity of culture (vs. EIA) 
and EIA (vs. culture) were observed between groups 1 and 2. 
The difference in prevalence and the agreement of sensitivities and specifities 
between the two groups are essential conditons for the application of the 
statistical approach described by Hui and Walter [4). If neither culture nor EIA is 
used as the standard, sensitivities of both diagnostic methods equal 90% and 
the equivalent specifities approach 100% (Table 5). 
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Table 4. Prevalence of positive culture and sensilivilies and specifities of culture 
and Enzyme Immunoassay (EIA): analysis of cervical specimens lor two age 
groups, wilh culture or EIA as standard. 
Measurement 
Prevalence of positive 
cullure 
Sensitivity' of positive 
culture 
Specifity' 01 culture 
Sensitivityt 01 EIA 
Specifityt of EIA 
'With EIA as slandard. 
tWith culture as standard. 
Percenlage with Indicated Result 
Group 1 Group 2 
5.6 11.6 
93 91 
99.2 98.5 
87 89 
99.6 98.8 
Table 5. Prevalence 01 gonorrhoea and sensitivities and specifitities of culture and 
Enzyme Immunoassay (EIA), with neither culture nor EIA as slandard. 
Measurement Percentage (95% Confidence Limits) 
Prevalence of gonorrhoea group 1 5.9 (1.7-10.3) 
Prevalence of gonorrhoea group 2 12.7 (7.7-17.7) 
Sensilivity of culture 90 (70-100) 
Specifity of cullure 99.8 (97.4-100) 
Sensilivity of EIA 90 (66-100) 
Specifity of EIA 100 (98.3-100) 
The influence of the sampling order of cervical and urethral specimens on results of 
EIA and culture is shown in Table 6. For cervical specimens the sensilivity of the 
EIA was 91 % (95% confidence limits, 72-99%) if the sample was taken firsl, and 
only 85% (66-96%) if Ihe sample was taken second. For urethral specimens the 
sensitivity of Ihe EIA was 88% (64-99%) if the sample was taken first, and only 
56% (31-78%) if the sample was taken second. For cervical specimens the specifity 
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of the EIA was 99.3% (95% confidence limits, 97.3-99.9%) if the sample was taken 
first, and 99.2% (97.2-99.9%) if the sample was taken second. For urethral spe-
cimens the specifity of the EIA was 98.9% (96.9-99.8%) if the sample was taken 
first, and 98.9% (96.7-99.8%) if the sample was taken second. For both the 
cervix and the urethra, use of the X' test showed that the differences observed 
were not significant. 
Table 6. Eflect of sampling order of cervical and urethral specimens on the results 
of culture and Enzyme Immunoassay (EIA). 
Cult. + Cult. - Cult. + Cult. -
Sample EIA + EIA + EIA - EIA -
Cervix 
EIA sample first 21' 2 2 264 
Culture sample first 23 2 4 425 
Urethra 
EIA sample first 15 3 2 269 
Culture sample first 10 3 8 262 
'Number of specimens giving indicated result. 
Cervical samples from four patients were positive in tI1e EIA but gave negative 
cultures. The urethral sample from one 01 these patients was positive in both EIA 
and culture. Another patient who was suspected of having gonoccoccal adnexitis 
sought treatment elsewhere, and thus evaluation was impossible. Urethral samples 
from six patients were positive in the EIA only. Cervical samples from three of 
these patients were positive in both EIA and culture. The remaining three patients 
had cervical samples negative in both EIA and culture. Cervical specimens from six 
patients gave positive cultures but negative EIA results. One of these women had a 
positive result for both EIA and culture of the urethral specimen. 
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Discussion 
On the basis of cervical cultures, the prevalence of gonorrhoea among the prosti-
tutes screened in this study was 8.7% (Table 2). In view of the regular check-ups 
ondergone by these women, this prevalence is rather high. 
For cervical samples the EIA showed a sensitivity of 88% and a specifity of 99.2% 
(Table 2). The high predictive value of a negative EIA (98.9%, Table 2) for cervical 
samples makes this test very suitable for gonorrhoea screening of a group of pros-
titutes with a fairly high prevalence of gonorrhoea. 
In the analysis of a new diagnostic test for gonorrhoea, culture for N. gonorrhoeae 
is usually accepted as the standard; its sensitivity and specifity are taken to be 
100%. By dividing the patients according to age into two populations with different 
prevalences of positive cultures (Tables 3 and 4), it became possible to apply a 
statistical model in which neither test served as standard [4J. According to this 
model the sensitivity of culture was 90% (95% confidence limits, 70-100%), while 
the sensitivity of the EIA was also 90% (95% confidence fimits, 66-100%; Table 5). 
In our study EIA was very sensitive and specific in comparison with culture (Table 
5). 
Aardoom et al. [2J used the EIA among a group of 102 prostitutes and obtained a 
sensitivity of 92% (95% confidence limits, 62-100%) and a specifity of 97% (95% 
confidence limits, 91-99%). Danielson et al.[5J found that the EIA had a sensitivity 
of 91% and a specifity of 100% among a group of 150 women attending a STD 
clinic. These results were better than those observed by others [6-8J. 
In our study we observed that, when sample material for the EIA was taken before 
that for culture, the sensitivity of the EIA was higher. This observation applied more 
to urethral than to cervical samples (Table 6). However, the differences observed 
were not statistically significant (X' test). 
In a number of cases there was discordance between results of the EIA and results 
of culture. Some patients had a positive EIA and a negative culture. This finding 
could be the result of the presence of dead gonococci killed by previous use of 
antibiotics or disinfectants. Or, the discrepancy might be attributable to cross-
reactions with other microorganisms or increased sensitivity of gonococci to antibi-
otics contained in selective nutrient media. A negative EIA and positive culture 
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might result from a deficiency in the spectrum of the antibodies contained in the 
EIA kit. On the other hand, it is conceivable that gonococcal antigen is masked by 
the presence of local antibodies of the IgA type. 
A major disadvantage of performing the EIA without culture is the lack of insight 
into the resistance of N.gonorrhoeae to antibiotics, in particular a lack of insight into 
the prevalence 01 JJ.lactamase-producing gonococci. However, rapid tests like the 
EIA can be very important aids in counteracting dissemination of N.gonorrhoeae 
because early identification of inlected persons permits early treatment. This impor-
lance is even greater when such tests are used for identification of promiscuous 
carriers of gonococci, e.g., sex-club women and prostitutes. Within the latter group 
women who are positive could be inlormed of the result on the day 01 the test and 
be asked to relrain from work and to report next day lor culture and treatment. 
Indeed, in Rotterdam the EIA is used in such a way. Enzyme immunoassay-
positive patients are tested again belore treatment, and gonococcal cultures are 
perlormed during this investigation. 
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CHAPTER 7 
EVALUATION OF AN ENZYME IMMUNOASSAY 
FOR DETECTION OF HERPES SIMPLEX VIRUS ANTIGEN 
IN GENITAL LESIONS 

Abstract 
To evaluale a non-marketed research prototype of a solid-phase enzyme im-
munoassay for detection of herpes simplex virus in genital lesions, 154 clinical 
specimens were collected from 127 men and 27 women with symptoms suggeslive 
of herpes simplex virus infection (erylhema, vesicles, ulcers and crustae). The 
samples were tested using the assay and cultures on four monolayers of human 
embryonic lung fibroblasts and Vero cells. When Ihe culture was used as 
reference method, sensitivity was 76.9% and specifity 100% (prevalence 42.4%). 
Comparison of resulls by patient group showed that sensitivity was highest in 
material from patients with vesicles and ulcers. The highest sensitivity was obtained 
in specimens which developed a cytopathological effect within 48 h and in 
specimens with three or four positive cell cultures. These findings suggest that the 
assay is more successful in specimens with high virus titres. The enzyme 
immunoassay was found to be a rapid, moderately sensitive, highly specific test for 
detection of herpes simplex virus from genital lesions, but the usefulness of the 
assay is limited and culture methods should be preferred. 
Introduction 
The conventional culture method has so far been the most sensitive and specific 
technique of detecting herpes simplex virus (HSV). In combination with immu-
nofluorescence using type specific monoclonal antibodies the technique can be 
used to distinguish between HSV-1 and HSV-2. However, at least one day is 
required before the cytopathogenic effect (CPE) becomes visible; in some cases 
the culture only proves to be positive after as many as ten days due to the low 
amount of virus in the inoculum. Thus there is a need for a rapid, sensitive and 
specific diagnostic method. Immunofluorescence is very satisfaclory for confirming 
culture results and for typing, however its sensitivity is too low to warrant its use as 
a direct test [1). Several ELISA systems for direct HSV antigen detection have 
been evaluated [2-6). We evaluated a non-marketed research prototype of a 
sandwich method EIA in patients with genital lesions suggestive of HSV infection. 
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Materials and Methods 
Patients. Clinical specimens were collected from genital lesions of 127 men and 27 
women with symptoms suggestive of HSV inlection (erythema, ulcers, vesicles, 
crustae) and symptoms less suggestive of HSV (wounds, erosions). 
Samptes. The samples were taken with the aid of a dry cottonwooHipped plastic' 
shafted swab by lirmly rubbing the base of the lesion. Two samples were collected 
from each patient. The lirst sample (A) was placed in a tube containing 1 ml 
transport medium (Abbott, USA) and used for EIA and culture. The second sample 
(B) was ptaced in a transport medium of the Regional Virological Laboratory, 
Rotterdam (3.5 ml Hanks salt solution supplemented with 0.5"/0 gelatin, gentamicin 
and nystatin) and used for a second culture. The major difference between the two 
transport media was that the Abbott medium did not contain nystatin. All samples 
were stored at 4 °c for no longer than three days until processed. 
Culture. HSV was cultured on monolayers of human embryonic lung libroblasts 
(HEL) and Vero cells (Flow Laboratories, UK). After removal of the medium fluid 
from the tubes 200 ~I of the patient samples was inoculated for 2 h at 35° C. The 
inoculum was then replaced by 1.5 ml maintenance medium (MEM-Hanks, Gibco) 
and gentamicin, supplemented with 5% fetal bovine serum and 1% newborn bovine 
serum lor HEL and Vero-cetls respectively, and the tubes were incubated at 35°C. 
They were examined after overnight incubation (or after two days on the weekend) 
and then every two days lor 14 days. In the case 01 a positive culture the virus was 
subtyped by indirect immunofluorescence using type-specilic monoclonal antibodies 
(Orthodiagnostics, Belgium). 
Enzyme immunoassay. The EIA was a non-marketed research prototype (Abbott) 
lor detection 01 HSV antigen. The tubes containing the clinical samples were 
shaken on the Vortex lor 15 s. The excess fluid Irom the swab was removed by 
pressing and rotating the swab against the side of the tube, whereupon the swab 
was discarded. A polystyrene bead pretreated to permit adsorption of HSV was 
added to each well 01 a ptastic plate and 200 ~t 01 sampte material was then 
introduced into the wells. Three negative controls and a panel of lour 
positive controls with the different antigen titres in duplicate were tested simulta-
neously. The wells were covered with adhesive seats and the plates were incu-
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bated for 120 min in a water bath at 37°C. Alter a washing procedure three 
rinsings with distilled water using a pentawasher (Abbott), 200 ~I antibody 
preparation (rabbit) and then 200 ~I conjugate (goat horseradish peroxidase-
conjugated antibody to rabbit immunoglobulin G) were added. Each step was 
followed by incubation for 60 min in a water bath at 37°C and the washing 
procedure described above. The beads were then transferred to 5 ml cuvettes; 300 
~I substrate (orthophenylene diamine with H,O,) was added and the cuvettes were 
incubated for 30 min at room temperature. The reaction was stopped by adding 
1 ml N H,SO,. This resulted in a yellow colour change in samples containing HSV 
antigen. Alter mixing the colour intensity was read at 492 nm on a Quantum 
spectrophotometric analyser (Abbott) against a substrate blank. Test results with an 
absorbance value of 0.100 00 plus the average of negative controls were regarded 
as positive. 
Statistical Analysis. The sensitivity, specifity and predictive value of a positive and a 
negative test result were calculated by the method of Vecchio (7J. The EIA results 
were compared with the culture results for samples A and B and with the combined 
results. 
Results 
Comparing tile EIA of sample A with the tissue culture results of samples A and B 
together, 50 of the total of 154 samples were positive both in the EIA and in cell 
culture, and 15 were positive only in cell culture (Table 1). Not a single sample was 
positive in the EIA and negative in combined cell culture methods. For the entire 
group this implied a sensitivity of 76.9% (90% confidence limits 66.71-85.1) and a 
specifity of 100% (95% confidence limits 96.69-1 00.00) (Table 2). The sensitivity of 
the EIA in the 127 men was 79.6% (39/49) and that in the 27 women was 68.8% 
(11/16). In the patient groups with various symptoms the sensitivity varied from 
57.1% to 87.1%. The specifity was again 100% for all groups. 
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Table 1: Detection of herpes simplex virus by enzyme immunoassay and culture in 
154 patients with various symptoms. 
Assay pas. Assay neg. Assay neg. 
Patient group N Culture pas. Culture pas. Culture neg. 
Men 127 39 10 78 
Women 27 11 5 11 
Erythema 41 11 7 23 
Vesicles 12 7 2 3 
Ulcers 65 27 4 34 
Crustae 8 0 0 8 
Other symp- 28 5 2 21 
toms 
Table 2: Prevalence of a positive herpes simplex virus culture, sensitivity, specifity 
and predictive values of a positive and negative result of the enzyme immunoassay 
versus culture in various patient groups. 
Patient Prevalence 
group N pas. culture Sensitivity Specifity PPV NPV 
Men 127 49/127 39/49 78178 39/39 78/88 
Women 27 16/27 11/16 11/11 11/11 11/16 
Erythema 41 18/41 11/18 23/23 11/11 23/30 
Vesicles 12 9112 7/9 3/3 717 3/5 
Ulcers 65 31/65 27/31 34/34 27/27 34/38 
Crustae 8 018 010 8/8 010 8/8 
Other 28 7/28 517 21/21 515 21/23 
The resulls with samples A and B are listed in Table 3. Of the sample A cultures 
51 proved positive; 8 of these were missed by the EIA (sensitivity 84.3%). Four 
samples were false positive in the EIA (specificity 95.9%), however, these proved 
to be positive in the sample B cultures from the same patients. 
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Table 3: EIA resulls compared with cell culture results in two separate samples 
transported in a commercial medium nol containing nystatin (Sample A) and a 
medium of the Regional Virological Laboratory, Rotterdam (Sample B). 
N EIA+ EIA- EIA+ EIA- Preva- Sensi- Specifity 
Cult+ Cull+ Cult- Cull- lence tivity 
A 149 43 8 4 94 34.2% 84.3% 95.5% 
(51/149) (43/51) (94/98) 
B 150 46 12 0 92 38.7% 79.3% 100% 
(58/150) (46/58) (92/92) 
On comparison with culture results for sample B, the sensitivity of the EIA was 
79.3% and the specifity 100%. 
HSV-1 was isolated in tissue culture from 11 of the total 65 positive cullures and 
HSV- 2 from 54. The EIA was positive lor HSV-1 in 10 (sensitivity 91%) and lor 
HSV-2 in 40 instances (sensitivity 74%). The tissue cultures were studied for CPE 
over a period of 14 days. After two days 41.5% of the positive cullures showed a 
CPE, after three days 65%, after four days 85% and after five days 92%. HSV-1 
was cultured for an average of 4.6 days before a CPE occurred, and HSV-2 for an 
average of 2.9 days. In Table 4 the sensitivity of the EIA is related to the number of 
days required for the culture to show a CPE. 
For HSV-2 , 24 cultures were positive after two days. Of these, two were missed 
by the EIA (sensitivity 91.7%). In 30 positive cultures three or more 
Table 4: Relationship between number of days until cytopathological effect (CPE) 
develops in tissue culture and EIA sensitivity for HSV types 1 and 2. 
HSV Number of EIA pas EIA neg Sensitivity 
type days for CPE Cult pas Cult pas 
Type 1 1st+2ndday 3 0 3/3 (100%) 
;, 3 days 7 1 7/8 ( 88%) 
Type 2 1st + 2nd day 22 2 22/24 (92%) 
;, 3 days 19 11 19/30 (63%) 
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Table 5: Relationship between number of positive cell cultures of the four cell 
cultures started per patient sample and the EIA results. 
Number posi- Number %of EIA pos EIA neg Sensiti-
tive cultures total Cult neg Cult pos vity EIA 
1 5 8 3 2 60% 
2 20 31 11 9 55% 
3 8 14 6 2 75% 
4 32 48 30 2 94% 
days were required before a CPE was observed; 11 were missed by the EIA 
(sensitivity 63.3%). 
In Table 5 the sensitivity of the EIA is related to the number of positive cultures 
per patient. For samples with 1 and 2 positive cultures the sensitivity was 60% 
and 55% respectively, while for samples with 3 and 4 positive cultures the sen-
sitivity was 75% and 93% respectively. For samples from vesicles on average 3.6 
of the 4 cultures were positive; the corresponding figure samples from ulcers and 
erythema was 3.0 and 2.6 respectively. 
Discussion 
Other investigators [2-61 have already evaluated several ELISA systems for direct 
detection of HSV antigen and the first results were very promising. Vestergaard [21 
reported 97% agreement with cutture results. Land [3], using commercially 
available antibodies against HSV in a personnally developed ELISA system, 
attained 94% sensitivity and 93% specility in 457 samples from patients. 
Using a commercial ELISA system (Orthodiagnostics), Morgan [4] attained 72.3% 
sensitivity and 100% specility in 263 samples from symptomatic patients. Using the 
same test, Warford [5] obtained poor results with cervical samples from 
asymptomatic women attending an obstetric out-patient clinic. Sensitivity in this 
study was 40-44% and many false-positive test results were obtained. Warford's 
results with skin lesions were better. USing the same ELISA system, Sewell [6] 
attained 69.7% sensitivity and 93.3% specifity in 136 samples from patients with 
suspected HSV infections. In this last study the EIA (Orthodiagnostics) was found 
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to be more sensitive in clinical samples which rapidly developed a CPE in the 
culture. In our study using a non-marketed research prototype 01 an ELISA for HSV 
antigen, the sensitivity of the EIA was 76.9% in relation to the combined culture 
results with samples A and B, and the specifity 100%. In routine works, however, 
an additional sample is rarely used. The first swab, which was placed in Abbott's 
transport medium, was found to yield fewer positive results than the medium of the 
Regional Virological Laboratory. The number of women in our study was too small 
to warrant conclusions on the sensitivity of the EIA in this group. The same applies 
for the groups with vesicles and crustae and the group with other symptoms. A 
striking fact is that HSV was cultured from 7 of the 21 patients with less obvious 
lesions. The sensitivity of the EIA was highest in patients with ulcers (87%). As 
ulcers may pose more diagnostic problems than vesicles, a rapid diagnostic test 
could be useful in such cases. HSV-l was found in 11 patients, however to deter-
mine the sensitivity of the test for type 1, a larger group of patients with HSV-l 
would have to be studied. 
In this study we used two criteria to estimate roughly the amount of virus antigen: 
the first was the speed with which the cell cultures developed a CPE, and the 
second was the number out of a total of four tissue cultures showing a CPE. These 
variables are however influenced by virus characteristics, such as rate of growth 
and preference for a particular cell type. In the samples containing more virus 
particles according to the above criteria, the EIA gave distinctly better test results. 
New diagnostic tests should also be evaluated in patient samples containing only 
little antigen. A disadvantage of the EIA method is that it is not possible to perform 
further tests to differentiate between HSV-l and HSV-2 since the virus is not 
isolated. The lower sensitivity in comparison with the culture method is another 
disadvantage which would be of particular importance in patients suffering from 
serious herpeOc infecOons. Although not applicable to the non-commercial prototype 
studied here, the advantages of the EIA method in general are the low cost in 
comparison with culture, the speed of the test in which results can be known within 
six hours, and the fact that less quallified laboratory personnel can perform the test. 
In conclusion, the usefulness of the non·commercial prototype we tested would 
appear to be limited and culture methods are still to be preferred. 
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CHAPTER 8 
EVALUATION OF A DOT IMMUNOBINDING ASSAY FOR 
DETECTION OF 
HERPES SIMPLEX VIRUS ANTIBODIES 

Abstract. 
To evaluate the value of a dot immunobinding assay (OIA) using glycoprotein G 
from herpes simplex virus type 2 (HSV-2) for detection of anti-HSV-2 antibodies in 
sera of 219 patients, the sera were tested using the OIA and Western Blot 
Analyses IY'/BA). The highest number of positive results were observed in patients 
with recurrent episodes. From 44 patients with recurrent HSV-2 infection, 39 (88%) 
were positive in the OIA and 41 (93%) were positive in WBA. In 82 sera of patients 
with HSV-2 infections 1-5 weeks after onset, the sensitivities of both assays were 
much lower: 40% for WBA and 20% for OIA. Fifty sera from schoolchildren reacted 
neither in WBA nor in OIA to detect HSV-2 antibodies. In 47 patients with early 
genital or extragenital HSV-1 infections, six were positive for HSV-2 antibodies in 
WBA and three in OIA. The majority (4/6) of the discordant results occurred in 
patients with genital lesions. In 19 patients with recurrent HSV-1 infection, one 
serum reacted in OIA and WBA. From 13 patients with recurrent herpes labialis two 
sera reacted in OIA and in WBA. In conclusion the OIA using glycoprotein G of 
HSV-2 is very useful for rapidly testing large numbers of sera for HSV-2 antibodies. 
In both assays, the best results were obtained in patients with recurrent episodes. 
Introduction 
Herpes simplex virus (HSV) can cause lesions at many different sites. In 80% of 
the cases, genital lesions are caused by herpes simplex virus type 2 (HSV-2), 
whereas lesions located elsewhere on the body are usually caused by herpes 
simplex virus type 1 (HSV-1). However, the nature and the location of the lesions 
provide insufficient information for distinguishing between the two types which 
requires isolation and typing of the virus. In order to establish whether a patient has 
ever been infected the detection of type-specific antibodies would be useful. The 
two viruses have a 50% homology in their genome so that they have similar 
antigenic determinants. For this reason, it is difficult to develop immunological 
assays which can be used to distinguish Circulating antibodies against HSV-1 from 
Circulating antibodies against HSV-2. The methods most commonly used to 
distinguish the two types of antibodies are based on the difference in titers of 
neutralizing antibodies against the two types (Rawl's index) [1}. Virus neutralization 
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tests are very laborious. The sensitivity and the specifity of such tests are low, 
especially wilen antibodies against both virus types are present in the same 
patient. Neither the complement-fixation test (CF) nor the immunofluorescence test 
can be used to detect type-specific antibodies. However, the complemenHixalion 
test in combinalion with immunofluorescence test for IgM antibodies is very useful 
for dislinguishing between early and recurrent infeclions. Western Blot analysis has 
been discribed by several aulhors [2-7), and is more useful for demonstraling 
anlibodies to HSV-2. In 1984, a previously described HSV-2 induced glycoprotein G 
(glycoprotein G2) with a molecular weiglh of 92 KD (8) was idenlified as a HSV-2-
specific protein [9, 10). This protein, purified using immuno-affinity columns or 
columns containing helix pomalia lectin can be used in various serologic assays 
[6,7,11-13). In the present report, our results with the WBA and the DIA using helix 
pomatia (HPA)-Ieclin column purified glycoprotein G2 as anligen are described. 
Sera from palients in whom cultures for HSV-1 or HSV-2 were positive and sera 
from controls were tested in these two assays. 
Patients and Methods 
Patients. If possible acute phase sera and reconvalescence sera were obtained 
from palients with culture positive HSV-1 and HSV-2 infections. The palients with 
HSV-2 infections were divided in two groups. Group A consisted of 41 palients with 
early infections. A patient was recorded as having an early infection if a 
seroconversion was either measured in the complement~fixation test for HSV, or no 
seroconversion was measured but IgM antibodies were present. Group B consisted 
of 44 patients with late infeclions. A patient was recorded as having a late infection 
if the patient either had a history of recurrent episodes with HSV or HSV antibodies 
were present in complement-fixalion test, but no seroconversion and no IgM 
antibodies were detected. Sera of 66 palients with culture posilive HSV-1 
inleclions, sera of 12 patients with recurrent herpes labialis and sera of 19 palients 
with Varicella lostervirus infeclions were tested. The control group consisted of 50 
schoolchildren between the age of 6-10 years, because HSV-2 infections would be 
unlikely at this age. 
Antigen preparations. HEp2- cells were grown in Oplimem medium (Gibco, UK) 
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supplemented with 4% fetal bovine serum and 1% glutamine. Hep-2 cells were 
maintained in Optimem supplemented with 2% fetal bovine serum and 1% 
glutamine. Semi-conlluent monolayers in 75 cm' plastic flasks were infected with 
HSV-l of HSV-2 (5-10 pfu/cell) isolated from two patients. Wilen cytopathogenic 
effect was observed in 75% of the cells (for HSV-l after approximately 24h, for 
HSV-2 after approximately 7211), the cells were scraped into the medium, 
centrifuged for 10 min at 500 x g and washed three times with cold phos-phate-
buffered saline (PBS, pH 7.2). The pellet was then resuspended in 0.6 ml PBS per 
flask and the protein concentration was measured (Biorad protein assay 
microprocedure). The suspension was pelleted again. For WBA [2,3) the pellet was 
resuspended in electrophoresis sample buffer (ESB) containing 1 % Sodium dodecyl 
sulphate (SOS), 1% mercaptoethanol, 0.0625 M Tris, 10% glycerol, 0.001% 
bromphenol blue at a final protein concentration of 700-1 000 ~g/ml, boiled for 10 
min and stored at -80 'c until use. For immunodotting [14) the pellet was 
resuspended in 4 ml 1% Triton Xl00 in Tris-buffered saline (TBS) pH 7.5. After 
extraction in the cold for 10 min, the suspension was centrifuged for 60 min at 
100,00 x g at 4 'C. The supernatant was stored at -80 'c until use. Mock infected 
cells were treated in the same way. 
Western Blot Analysis. The frozen HSV- and Mock infected cell-Iysates in ESB 
were thawed and loaded onto a 9% discontinous polyacrylamide gel containing 
0.1 % SOS and cross-linked with 0.23% methylenbisacrylamide [2,3). After 
electrophoresis, the proteins were transferred onto nitrocellulose (NC) sheets. Dried 
NC sheets were stored at -20 'c 
Lectin affinity chromatography. Helix pomatia Lectin-Sepharose 6MB columns 
(Pharmacia, Sweden) in 2 ml plastic syringes (bed volume 1 ml) with a filter paper 
(nr 3, Whatman, England) on the bottom were washed with 10 bed volumes 
starting buffer (1% Triton Xl00 in TBS containing 0.15M NaCI, 0.02M Tris, pH 7.5). 
One ml of the thawed HSV-l, HSV-2 or control antigen was added and incubated 
for 15 min at room temperature. After incubation, the non-bound glycoproteins were 
washed away with lObed volumes of starting buffer. The bound glycoproteins were 
eluated with 5mM N-acetylgalactosamine (Sigma, USA) in the same buffer [11-15). 
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Fractions of 0.05 ml were collected and fractions 2 and 3 were pooled and stored 
in glass ampules at -80 C. One ~I of the eluate of HSV-1, HSV-2 and Mock infec-
ted cells was placed on NC strips of about 7 x 50 mm. The strips were dried 
overnigl1l at room temperature and used immediately or stored at -20 DC. 
Enzyme assay. Nitrocellulose strips for WBA and NC strips carrying the HPA lectin· 
purified antigens for DIA were incubated together with 10 ml blocking buffer (PBS 
pH 7.2 with 5% goat serum and 5% non-fat dried milk) during 10 min at room 
temperature on a rotating platform. The 100 ~I of test serum was added and 
incubation was continued overnight at room temperature. Thereafter, the strips 
were washed three times for 5 min in washing buffer (PBS pH 7.2, 0.05% Tween-
20). Alkaline phosphatase-conjugated rabbit anti-human IgG (Dakopatts, Denmark), 
in blocking buffer was added and the strips were incubated for 2 h at room 
temperature on a rotating platform. Strips were washed four times with washing 
buffer, after which the strips were rinsed with substrate buffer (0.1M Tris, 0.1M 
NaCI, 50mM MgCI2) and stained with Nitroblue T etrazolium Chloride (NBT) and 5· 
bromo-4-chloro-3-indolyl phosphate (BeIP, p- toluidine salt) (Bethesda Research 
Laboratories Life Technologies, USA) for approximately 20 min at room 
temperature. The strips were dried overnight before they were read [6,16). For DIA, 
a reaction was regarded to be positive for HSV-2 antibodies when a purple dot was 
visible where the HSV-2 antigen had been dotted. For WBA, a blot was regarded to 
be positive for HSV-2 antibodies when the 92 KD band in the HSV-2 antigen lane 
was visible. 
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Results. 
To demonstrate the reaction patterns in WBA and DIA. some results obtained with 
sera from patients with either early or recurrent HSV-1 or HSV-2 infections are 
shown in Figures 1 and 2. Sera from patients with either recurrent HSV-1 or HSV·2 
infections reacted strongly with many HSV-1 and HSV-2 proteins in a WBA (Figure 
1, strips 1, 2 and 6). Only weak or no reactions were detected with sera from 
patients with early HSV-2 infections (Figure 1, strips 3, 4, 5). 
2 1 C 21C2.1C 21e 2le 
" 1 c 
< 94 
92 > 
I < 67 
p40 ) < 43 
p30 > < 30 
" 
3 4 5 6 
Figure 1, Western Blot Analysis. Strip 1 and 2: patients with recurrent HSV-2 
infections. Strips 3-5: patients with early HSV-2 infections (21, 18, 26 days after the 
onset respectively). Strip 6: patient with recurrent HSV-1 infection. 
1 = HSV-1 antigen, 2 = HSV-2 antigen, C = Control antigen 
arrows left: glycoprotein G2 (92K), proteins P40 and P30 are indicated. 
arrows right: molecular weight markers are indicated 
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Figure 2. Dot Immunobinding Assay. SI = acute phase serum, SI! = reconva-
lescence serum, C = control antigen, 1 = HSV-1 antigen, 2 = HSV-2 antigen. 
Patient A: early infection with HSV-2. Patient B: recurrent infection with HSV-2. 
Patient C: early infection with HSV-1. Patient 0: recurrent inlection with HSV-1. 
However, in a serum from a patient with recurrent episodes of HSV-1 infection, no 
reaction could be demonstrated with a 92 KO glycoprotein of HSV-2 (Figure 1, strip 
6). This glycoprotein is known to be the HSV-2 type-specilic glycoprotein G2 [5J. In 
order to lacilitate easy screening of sera for the presence of HSV-2-specilic 
antibodies, glycoprotein G2 was isolated by affinity chromatography on Helix 
pomatia Sepharose 6 MB columns. Others have shown that chromatography of 
extracts of HSV-1 in Helix pomatia columns led to the purification of glycoprotein C 
of molecular weight 125-130 KO [11, 13J. Glycoprotein C from HSV-1 carries type-
common antigenic determinants. Purified glycoprotein G2 from HSV-2, glycoprotein 
C from HSV-1, and control cell extracts were used for a OIA. Sera from patients 
with either HSV-1 or HSV-2 infections reacted with the type-common HSV-1 
glycoprotein C (Fig 2, A-D), but only sera from patients with HSV-2 infections 
reacted with the type-specilic HSV-2 glycoprotein G2 (Figure 2, A and B). No 
reactions were detected with control antigens. 
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Sera taken one to five weeks after the onset of cfinical symptoms from patients 
with early HSV-2 infections and from patients with recurrent infections were tested 
in WBA and DIA. The results are presented in Table 1. In Table 1, the differences 
in reactivity between sera from patients with late and early infections are shown. In 
93% of the cases, sera from patients with late HSV-2 infections reacted in the WBA 
with the 92 KD protein and in 89% of the cases in the DIA with purified glycoprotein 
G2. Patients with early infections showed a lower reactivity: 40% reacted in WBA, 
20% reacted in DIA, but there was a tendency for additional reactions if a longer 
period has elapsed between the onset of clinical symptoms and the date the serum 
was taken. Some patients developed anti-glycoprotein G2 antibodies only after 3-5 
weeks, whereas others did not develop anti-glycoprotein G2 antibodies at that 
moment. The same sera were used for the results presented in Table 2. From 40 
sera with a reciprocal titer in CF ';4, 8 (20%) reacted in WBA and 4 (10%) in DIA. 
From the 42 sera with a reciprocal titer in CF :>8, 25 (60%) reacted with glycopro-
tein G2 in WBA and 12 (29%) in DIA. 
In order to evaluate the specility of the WBA and the DIA, sera from patients 
with HSV-1 or VZV infections and sera from schoolchildren were tested. 
Table 1: Results of 82 sera from 41 patients with early HSV-2 infections and in 44 
sera of 44 patients with late HSV-2 infections using WBA and DIA. 
patient group N WBA DIA 
HSV-2 positive gG2 positive 
(%) (%) 
Early infection 
week 1 35 6 (17%) 3 (9%) 
week 2 17 8 (47%) 5 (29%) 
3-5 weeks 30 19 (63%) 8 (27%) 
Total 82 33 (40%) 16 (20%) 
Late infection 44 41 (93%) 39 (89%) 
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Table 2: Results 0141 acute phase and 41 reconvalescence sera obtained Irom 41 
patients with early HSV-2 infection using WBA and DIA. The same sera were 
divided according to the reciprocal titer in CF ,; 4 or ;, 8. 
Serum N WBA HSV-2 positive DIA HSV-2 positive 
(%) (%) 
Acute Phase 41 7 (17%) 5 (12%) 
Reconvalescence 41 26 (63%) 11 (27%) 
CF,; 4 40 8 (20%) 4 (10%) 
CF ;, 8 42 25 (60%) 12 (29%) 
Total 82 33 (40%) 16 (20%) 
Table 3: Results of the sera from patients with genital or extragenital HSV-1 
infections, in patients with recurrent herpes labialis, in schoolchildren, and in 
patients with Varicella Zoster virus infection using WBA and DIA. 
Patient group N WBA HSV-2 positive DIA HSV-2 positive 
(%) (%) 
HSV-1 infection 66 7 (11%) 4 (6%) 
Recurrent 
herpes labialis 13 2 (15%) 2 (15%) 
Schoolchildren 50 0(0%) 0(0%) 
Varicella Zoster 19 0(0%) 0(0%) 
The results are shown in Table 3. There were no cross-reactions with sera from 
schoolchildren and sera from patients with VZV infection. However, seven patients 
with culture positive HSV-1 infection and two patients with recurrent herpes labialis 
reacted with glycoprotein G2. The results of the patients with discordant serology 
are presented in Table 4. In a number of cases, a history of HSV-2 infection could 
not be totally excluded. 
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Table 4: Discordant results using WBA and dot immunobinding assay in patients 
with genital of extragenital HSV-1 infection and patients with recurrent herpes 
labialis. 
Patient Age WBA Dot Clinical 
nr years HSV-2 92K information 
Genital or extragenital HSV-1 infection 
54 22 + - m', urethral vesicles 
241 6 + - 1', stomatitis 
248 18 + + f, vulvar ulcerations 
252 21 + - f, vulvar vesicles 
254 61 + + f, herpes labialis, TPHA + 
257 22 + + f, vulvar ulcerations 
53 19 + + f, vulvar vesicles 
Recurrent herpes labialis 
149 
152 
1m = male 
'f = female 
26 
24 
+ + 
+ + 
'rec.h.lab = recurrent herpes labialis 
'rec.h.gen = recurrent herpes genitalis 
n.d. = not done 
Discussion 
f, rec.h.lab'/h.gen' 
f. rec.h.lab 
Cul-
ture 
HSV-1 
HSV-1 
HSV-1 
HSV-1 
HSV-1 
HSV-1 
HSV-1 
n.d. 
n.d. 
Western Blot Analysis has been described by several authors [2-6] and is more 
successful for identifying antibodies against HSV-2 then virus neutralization and 
plaque reduction tests. However, a lot of sera reacted with HSV-1 and HSV-2 on 
NC strips in WBA. In the cases of atypical reaction patterns, sera had to be 
absorbed with HSV-1 and HSV-2 antigens. Ashley et al [5] used a quantalive 
method by weighing the cut-out traCings from scanning densitometry. However, 
using this method it was difficult to distinguish between sera containing HSV-1 
antibodies and sera containing dual antibodies. In qualitative sense, densitometry 
was found to be useful in identifying the band corresponding to the HSV-2-specific 
glycoprotein G2 in the presence of HSV-1 antibody. Purified glycoprotein G2 can 
be used in glycoprotein G2-specific assays. 
Comparing WBA and glycoprotein G2-specific Immunodot Enzyme Assay, Ashley 
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et al [6) detected antibodies to HSV-2 in 25% of the sera using WBA and in 8% of 
the sera using Immunodot Enzyme Assay with sera obtained earlier than 21 days 
after the onset of primary HSV infection. Ninety-nine percent of samples were 
positive for HSV-2 in WBA en 96% were positive in Immunodot Enzyme Assay with 
sera obtained at least 21 days after onset of primary HSV infection. 
Lee [7) observed that 17% of the sera obtained within 10 days after onset and 95% 
of sera obtained more than 10 days after onset were positive in Immunodot 
Enzymatic Assay. The test was found to be very specific. None of the 631 sera 
from HSV-seronegative adults, children, nuns and patients with primary genital 
HSV-1 infections were reactive with glycoprotein G2 antigen. 
Lee [7) and Ashley [6) used immuno-affinity purified antigen for Immunodot 
Enzymatic Assay. 
We used Helix pomatia (HPA) lectin-purified HSV-2 glycoprotein G2 in dot 
immunobinding assay. Using dot immunobinding assay, we observed that 39 out of 
the 44 (89%) sera were positive from patients with late HSV-2 infections and 41 out 
of the 44 (93%) sera were positive using WBA. 
Swennerholm [11) used HPA lectin-purified antigens in an ELISA system. From the 
26 sera of patients with verified HSV-1 infections, eight contained antibodies 
against HSV-2 type-specific antigen. From the 26 sera of patients with verified 
HSV-2 infections, all demonstrated positive titers against HSV-2 specific antigen. 
Suchimkova [12) used HPA lectin-purified antigens in Solid Phase RIA for detection 
of HSV type-specific antibodies. Antibodies to HSV-2 were detected in 14 out of the 
16 subjects treated for genital herpes lesions (not cultured). Antibodies to HSV-2 
were not detected in any of the 57 children. 
In our hands the WBA was slightly more sensitive than DIA. 
In another study [5), the WBA was also observed to be slightly more sensitive. The 
difference between WBA and dot immunobinding assay is more prominent when 
early sera were used. This could be explained by the fact that reaction to antigens 
other than HSV-2 glycoprotein G2 occurred earlier. We used very stringent criteria 
for a positive WBA. Only a WBA with a reaction to HSV-2 glycoprotein G2 was 
regarded as positive. 
In patients with early HSV-2 infections, 6 out of the 35 (17%) sera taken in the first 
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week after the onset of clinical symptoms were positive using WBA, 3 (9%) were 
positive using DIA (Table 1). From the 17 sera taken in the second week after the 
onset of clinical symptoms 8 (47%) and 5 (29%) were positive using WBA and DIA 
respectively. From the 30 sera taken 3-5 weeks after the onset 19 (63%) were 
positive using WBA and 8 (27%) were positive using DIA. Twenty percent of the 
sera with a reciprocal CF titer s 4 were positive using WBA and 10% were positive 
using DIA, whereas 60% of the sera with CF titer;, 8 were positive using WBA and 
29% were positive using DIA (Table 2). The best method of recognizing type-
specific HSV-2 antibodies is to test sera taken three weeks or later after the onset 
of clinical symptoms or sera with CF titer;, 8. 
In our study, sera taken more then five weeks after onset of clinical symptoms of 
first episode were not available. From this study we are unable to answer the 
question whether HSV-2-specific antibodies in patients who once had a clinical epi-
sode can be detected. Neither the percentage of patients who once had a 
symptomless infection could be detected nor could the length of time the antibodies 
existed after one clinical or symptomless episode be established. 
From other studies [5, 7, 16J, the WBA and glycoprotein G2 immunodot assay turns 
out to be very specific. We observed that 7 sera were positive from a total of 66 
patients with proven HSV-l infection. In the study by Samarai [18J in patients with 
recurrent genital herpes, in one episode HSV-l was isolated, in another episode 
HSV-2 was isolated. Therefore it is possible to detect HSV-2-specific antibodies in 
patients from which HSV-l was isolated from the genitals. From sexually active 
adults with herpes labialis, a part will be once infected by HSV-2. Therefore it is not 
surprising to find HSV-2 specific antibodies in adults with herpes labialis. We have 
no explanation for HSV-2-specific antibodies in a 6 years old child hospitalized with 
stomatitis, from whom HSV-l was isolated. 
The use of immuno-affinity columns to purify glycoprotein G2 is more effective, and 
the product is more concentrated, than by using HPA-Iectin columns. However, 
monoclonal antibodies needed for immuno-affinity are not commercially available at 
present. It is relatively simple to purify glycoprotein G2 with HPA-Iectin columns and 
the HPA bound lectin is commercially available. Recently, glycoprotein Gl and 
glycoprotein G2 were expressed in recombinant-baculovirus-infected insect cells 
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[19J, and in E. coli [20J. 
In conclusion, the dot immunobinding assay using glycoprotein G2 is very useful for 
testing large numbers of sera rapidly. Both using WBA and DIA, the best results 
were obtained in patients with recurrent infections. For patients with an early HSV-
infection the best results were obtained using sera with a reciprocal titer in CF ;, 8 
or sera taken more than two weeks after the onset of clinical symptoms. 
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CHAPTER 9 
SUMMARY AND DISCUSSION 

SUMMARY AND DISCUSSION 
A review of the various sexually transmitted diseases (STDs) is presented in 
chapter 1. In addition, the importance of quick and accurate laboratory diagnostiCS 
is also discussed. At the time of writing, the laboratory diagnostics of the STDs 
such as Chlamydia trachomatis infections, gonorrhoea and herpes genitalis still 
mainly depend on the relatively slow and complicated culturing techniques for the 
causative microorganisms. 
An overview of the clinical manifestations and complications of the three above 
mentioned STDs is presented in chapter 2. 
Several problems which are still confronted in the serological diagnostics of the 
above mentioned 3 STDs are summarized in chapter 3. Uncomplicated infections 
of C. trachomatis, N. gonorrhoeae and herpes simplex virus (HSV) are superlicial 
skin anellor mucous membrane infections. These diseases evoke an inadequate 
systemic antibody response to enable diagnosis at the moment they become 
clinically manifest. Nevertheless, antibodies are detectable during the later stages 
and can remain in circulation for a number of years. This leads to the problem in 
distinguishing between an acute infection and a previously suffered infection. An 
acute infection can be recognized by the differences in the titres of the acute 
phase serum and the convalescent serum obtained at approximately two weeks 
interval. An additional problem is the high antibody titres which may also occur in 
healthy individuals as a resull of exposure to related microorganisms which show a 
high antigenic similarity, e.g. N. catharrhalis & N. meningitides with N. gonorrhoeae, 
C. pneumonia & C. psittaci with C. trachomatis and HSV-1 with HSV-2. 
In the combat against STDs, a sensitive and rapid diagnostic method is important 
for the quick therapeutic intervention in order to break the infection chain. A rapid 
and sensitive method would be ideal because it can be performed while the patient 
waits so that the diagnosis and the treatment can be established at the same 
consultation. However, the culture and the serological methods for these STDs are 
not quick enough for this purpose. Besides, such methods are mostly too 
complicated to be available at the location where the diagnosis is undertaken. This 
imposes special demands on the transportation because the microorganisms 
responsible for causing the STDs survive poorly under non-optimal conditions and 
147 
Can adversely affect the results of the culture. For this reason, a search has been 
and is being made for alternative methods for detecting the causative agents. Such 
melhods are based on: 
1. detection of antigens: antibodies against the microorganism raised in experi-
mental animals are llsed 10 delecl the pathogen in samples laken from the 
palients. 
2. The delection of the microbial DNA or RNA. 
3. The replication of the DNA or RNA which is subsequently used as proof for 
the presence of Ihe microorganism. 
Besides, in developing the diagnoslic melhods, it was allempted to make redundant 
the for Ihe patient unpleasant examinalion of the cervix, the urelhra, Ihe reclum 
and Ihe oropharynx. In addition, Ihe specific and sensilve lesls would enable the 
screening of certain groups at risk. 
During Ihe period in which the invesligalions described in chapters 4-7 were being 
conducted, allention was mainly focussed on Ihe melhods to detect anligens which 
were mostly performed in an ELISA sel-up. Advantages of Ihis Iype of tests are the 
speed and Ihe simplicity of execution, Ihe possibilily for aUlomalion and also the 
possibilily for no longer having to detecl living microorganisms as causative agents 
for STDs. The ELISA method for delecting C. trachomatis and to a lesser exlent, 
Ihe ELISA for detecting N. gonorrhoeae have penelrated as far as the routine -
laboralory. However, such methods have reached no further than the research 
laboralory for detecting HSV. The commercially available ELiSAs are not cheap. 
The advantages may only show up well when the number of samples from the 
patienls is large enough. When Ihe number of samples is relalively small, Ihese 
lests are conducled only in a "balch-wise" manner, whereby the advanlage of 
oblaining quick results is losl. The balance belween advanlages and disadvanlages 
of the lest for each microorganism may be differenl for each laboralory. 
The molecular biology-based deteclion methods such as hybridizalion and PCR are 
of prominent interest. The sensitivily of the commercially available hybridization 
tests, the probe assays for C. trachomatis and N. gonorrhoeae appeared not to be 
higher than that of Ihe respective ELiSAs. This was in conlrast to the sensitivity of 
the PCR. This technique is exlremely sensilive and in principle a single 
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microorganism can be detected in the samples Irom the patients. Initially, the poor 
specificity of the PCR was an important disadvantage which appears to have been 
overcome by the use of closed systems. The possibility to detect additional 
microorganisms in a single sample using different primers is a further advantage of 
this test. Using this test, it would be possible to establish an infection with C. 
Irachomatis and N. gonorrhoea in urine samples from men in the future. Thus, it 
would be unnecessary to take samples from the urethra thereby reducing the 
burden imposed on the patient. The presence of living microorganisms is 
unnecessary in these tests so that there is no decrease in the sensitivity because 
of non-optimum transportation conditions. 
These methods also have disadvantages. As such, the microorganism is not 
available for typing and testing for susceptibility which is particularly important for 
N. gonorrhoeae. Besides, the quantification of the detected microorganism is not 
possible. The result is either positive or negative without any gradation. The 
possibility to detect a very low number of microorganisms in case of C. Irachomatis 
is considered by some to be a disadvantage because it only involves a commensal. 
However, such a view is questionable because it involves a sexually transmissible 
microorganism whereby it is also important to trace and treat the asymptomatic 
carriers. 
Alternative methods for detecting chlamydia have been mainly searched for 
because there are many disadvantages associated with culturing this microor-
ganism. Initially, these alternatives were the ELISA and the IF for detecting antigen. 
Later the probe assay and the PCR were added. A review of the different 
techniques is presented in chapter 3. In chapters 4 and 5, an ELISA for detecting 
Chlamydia Irachomatis antigen is evaluated. 
In chapter 4, an investigation into 403 urethra samples from men is described. The 
patients were divided into groups according to the seriousness of the symptoms 
and the abnormalities present in the urine sediment. The sensitivity of the ELISA as 
compared with the culture varied from 50% in the group without symptoms or 
abnormalities in the urine sediment to 82% in the group with post-gonococcal 
urethritis. Other authors using urethra samples from men reported the sensitivity of 
the ELISA to vary from 66% to 100% [1-8). 
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In chapter 5, an invesligalion into the ELISA using samples from the cervix of 246 
women including the 135 women mentioned in chapter 4 is described. The number 
of leucocytes was semi-quantilatively determined in the smears of the cervix and 
scored from 0 (no leucocytes present) to 4 (more than 20 leucocytes per micr-
oscopic field). The sensilivity of the ELISA as compared with the culture varied 
from 50% in the group with no leucocyte to 100% in the group wilh more than 20 
leucocytes. In addilion, the patients were divided on the basis of the resulls of the 
culture. There was a significant difference in the results of the ELISA between both 
groups: The sensitivity was 54% in samples with less than 20 inclusions in the 
culture and 100% in samples with more than 20 inclusions in the culture. These 
results indicated that the sensitivily of the ELISA depended on the amount of 
antigen. The ELISA had an overatl sensilivily of 67% as compared with the culture. 
In other studies, using samples from the cervix, the sensitivily of the ELISA varied 
from 71 % to 98% (1,3,4,7-1 OJ. 
The results of the sensitivity varied considerably and could have been due to the 
following: 
1. The reference test. Most researchers used the cullure as the reference. 
However, this is not standardized and may be undertaken using different cell 
lines such as the HeLa 229 and McCoy cell lines which may also have been 
pre-treated in different manners, e.g. wilh DEAE-dextran or Cytochalazine B. 
In addition, cullures may also have undergone more than one passage. 
Finally, the cullure may also have been confirmed in various ways. Staining 
wilh iodine is relatively unsensitive, whereas staining wilh Giemsa followed 
by evaluation using dark-field illumination is more sensitive. Confirmation of 
the culture using immunofluorescence is the most sensitive method. II is 
clear that the observed sensitivity of the ELISA would depend on the 
sensitivity of the used cullure technique. 
2. The composition of the tested group of patients. Classification according to 
the clinical presentation, leucocyte score or abnormality in the urine 
sediment are very important for determining the sensitivily of the ELISA as 
illustrated in our study and in those by others (5,6,ll-13J. 
3. A correct sampling technique is essential for the diagnostics of Chlamydia. 
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The sample must contain enough cells because an intracellular 
microorganism is involved. An inadequate sampling would result in a low 
amount of antigen. The sequence in which the samples for the culture and 
the ELISA were taken also appeared, at least in men, to influence the 
results [4,11J. In a mouse model, Taylor-Robinson observed that the 
sensitivity of the ELISA for detecting C. trachomatis as compared with the 
culture was dependent on the sequence in which the samples were taken 
[14J. 
The manner of transportation may also have an effeci because non·optimum 
conditions would have an adverse effect on the viability of Ihe micro-
organism which in turn would adversely effect the results of the culture. 
Unfamiliarity with these various factors hampers the direct comparison of the 
results of the various studies. 
The specificity of the ELISA was determined using samples from patients 
consulting the outpatient department and in whom the results of the 
Chlamydia culture were negative. The specificity was observed to be 98.5% 
in men and 92% in women. These figures corroborate those reported in the 
literature which varied from 94.7% to 98% [6,13, 15J. 
In summary, the value 01 the ELISA in detecting antigen for the diagnostic of 
C.trachomatis infections is limited mainly because 01 the low sensitivity of the test. 
The test may be useful in situations where the culturing of the microorganism is not 
possible or when the transportation of the sample is not possible under optimal 
conditions. However, as shown in the studies described in chapters 5 and 6, one 
should realize that in half of the patients with a low amount of chlamydia antigen 
and/or few clinical symptoms, the results of the test may turn out to be negative. 
In chapter 6, a modified version of an earlier commercially available ELISA test, 
the Gonozyme for detecting gonococcal antigen was evaluated. In this study, the 
test was evaluated using samples of the cervix and the urethra obtained from 266 
prostitutes because the results of an earlier study in women had been disappointing 
[16J. The prevalence of gonorrhoea on the basis of the culture was 9.3% which 
was rather high taking into account that these prostitutes underwent regular 
medical check-ups. It was decided to randomize the sequence of taking samples 
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because it was suspected that the sequence in which the samples were taken may 
inlluence the results. The sensitivity of the ELISA was observed to be 88% 
(urethra) and 91% (cervix) provided that the cotton-swabs for the ELISA were taken 
first and 56% and 85% respectively if the cotton-swabs for the culture were taken 
first. The overalt sensitivity and specificity of the ELISA using samples from the 
urethra were 71 % and 98.9% respectively_ For the samples from the cervix, the 
overall sensitivity and the specificity of the ELISA as compared with the culture 
were observed to be 88% and 99.2% respectively. The predictive value for a 
negative cervix test was high (98.9%), so that this test was considered to be 
suitable for screening this group of women for gonorrhoea. These results 
corroborated the results (sensitivity 87.5% and specificity 98%) of another study 
[17J. However, Papas ian et al observed that using samples from the cervix, the 
Gonozyme had a much lower sensitivity of 74.4%, but the specificity was 99.2% 
[18J. In earlier studies, it appeared that using samples of the urethra from men, the 
Gonozyme performed welt with a sensitivity of 90% to 100% [17J and 97.3% [18J. 
A comparison of the results of various investigations is difficult due to the factors 
similar to those mentioned in the previous paragraph: differences in the reference 
test, differences in the composition of the patient groups and differences in the 
manner in which the samples were taken. Similarly, strains that are susceptible to 
vancomycin may be missed if a selective medium is used for culturing. The 
sensitivity of Gonozyme was also observed to decrease in similar manner to that of 
Chlamydiazyme when the samples from the patients containing little antigen were 
used [17,18J. 
In summary, excellent results with the ELISA were obtained in men with symptoms 
of urethritis. However, in this group of patients, the ELISA has hardly any 
advantages as compared with the much cheaper and quicker Gram-stained 
preparation. The situation is different for women, because the Gram-stained 
preparation of the samples from the urethra and the cervix are insensitive. In this 
case, the ELISA is a suitable alternative for the Gram-stained preparation and the 
culture. The last is especially true in situations where the transportation of the 
samples under optimum conditions is not possible and because the results of the 
ELISA are not inlluenced by non-optimum transportation conditions or cold storage 
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of the samples for a period of 14-26 days. In addition, the ELISA has advantages if 
quick diagnosis is required. This advantage is used in Rotterdam, where the ELISA 
is used for the weekly screening of prostitutes and women working in sex-clubs. 
The culture is the most sensitive and specific method to detect HSV and in 
combination with IF, can also be used to type the virus. However, it may take 1 to 
10 days for IIle CPE to appear. Various ELISA systems have been developed so 
that the results are quickly available. In the investigations described in chapter 7, 
an ELISA for detecting HSV (Abbot, USA) was compared with the culture in 
patients with genital lesions suspected of an HSV infection. The sensitivity of the 
ELISA as compared willl that of the culture was 76.9% and the specificity was 100 
%. When different groups of patients were compared, it appeared that the 
sensitivity (87%) of the ELISA was the highest using samples obtained from 
patients with blisters or ulcers. The sensitivity of the ELISA was also higher using 
samples in which CPE was observed within 48 hours (100% for HSV-1 and 92% 
for HSV-2). This indicated that the results of the ELISA improved with an increasing 
number of virus particles in the sample. 
Various ELISA systems (Dako, Ortho, Herpcheck, Welcome, Novo) were evaluated 
by different investigators [19-27). The specificity of all the tests was high (93% to 
100%). However, the sensitivity of the tests varied (34.3% to 98.6%) depending on 
the type of the test, the investigator and the group of patients that was investigated. 
In general, a low sensitivity was observed using samples of the cervix obtained 
from asymptomatic women [21,22,26). The sensitivity was higher using samples 
taken from lesions of patients with symptoms [25,26). In this last group of patients, 
it also appeared that the sensitivity of the ELISA was higher when the samples 
used were taken from lesions at an early stage [25). 
It appeared that the specificity of ELISA tests for detecting HSV antigen was good, 
but the sensitivity left a lot to be desired for. Highest sensitivity was observed using 
samples from patients with symptoms and lesions at an early stage which 
contained a high amount of antigen. However, these are the same samples in 
which CPE is observed within 48 hours in the culture, so that in such cases, the 
ultimate time gained is limited. This test adds little to the already available 
diagnostics for patients without symptoms or with lesions at a late stage. However 
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for lesions at a late stage, serological investigations do provide additional 
inlormation as described in studies in chapter 8. 
In these studies, two serological tests for detecting type-specific antibodies against 
HSV-2 were evaluated. The results of the dot immunobinding assay (DIA) with 
affinity-purified gG2 as the antigen were compared with the results of the Western 
Blot Analyses (WBA) and the culture. For this purpose, sera of 219 patients were 
divided into groups according to the type of the virus that was cultured and the 
symptoms. From the 44 patients with recurrent HSV-2 infections, 39 (88%) were 
positive using the DIA and 41 (93%) were positive in the WBA. Using 82 sera from 
patients, taken 1-5 weeks after the appearance of the first symptoms, the sensitivity 
of both the tests was much lower: 20% for the DIA and 40% for the WBA. Both the 
tests seemed to be very specific: antibodies against HSV-2 were not detected in 
any of the 50 sera from schoolchildren using either the DIA or the WBA. The WBA 
was more sensitive than the DIA, but is difficult to perform at a routine laboratory. 
The DIA is much simpler. However, at present, the purified glycoprotein G2 is also 
not commercially available. A type-specific serological test is a useful supplement 
to the already available diagnostiCS. The type-specific serology may provide 
valuable information in situations in which culturing is not or no longer possible 
such as in patients with lesions at a late stage or in patients without symptoms, but 
in whom there may be a specific query such as in risky pregnancy. 
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SAMENVATTING EN DISCUSSIE 

SAMENVATIING EN DISCUSSIE 
In Hoofdstuk 1 is een overzicht gegeven van de verschillende SOA's. Tevens is 
het belang van een goede en vooral snelle laboralorium-diagnosliek besproken. Op 
moment van hel schrijven van dit proefschrift berusl voor de SOA's veroorzaakl 
door C. trachomatis, N. gonorrhoeae en herpes simplex virus de laboralorium-
diagnose nog sleeds voor een belangrijk dee I op de rei alief Irage en 
gecompliceerde kweekmethode van deze ziekteverwekkers. 
In Hoofdstuk 2 is een overzicht gegeven van de klinische manifestaties en 
complicaties van de drie bovengenoemde SOA's. 
De serologische diagnostiek van de genoemde drie SOAs, die is samengevat in 
Hoofdstuk 3, levert enkele specilieke problemen op. Ongecompliceerde infecties 
met C. trachomatis, N. gonorrhoeae en herpes simplex virus zijn oppervlakkige 
huid eniof slijmvlies infeclies. Op het moment dat zij klinisch manifesl worden, 
hebben zij tot een nog onvoldoende sterke systemische antilichaam respons geleid 
om deze een rol te laten spelen bij de diagnose. Niettemin zijn in latere stadia wei 
anti Ii cham en detecteerbaar, die meerdere jaren in de circulatie aanwezig kunnen 
blijven. Dit geeft problemen bij het onderscheid tussen een acule infeclie en een 
vroeger doorgemaakte infectie. Door gebruik te maken van twee serummonsters 
welke ca. 2 weken na elkaar worden afgenomen, het acule fase serum en het 
reconvalescentie serum, kan een acute infectie vaak als zodanig worden herkend 
aan de titerverschilen van deze twee monsters. Een bijkomend probleem vormen 
de hoge antilichaamtiters, die bij gezonde personen kunnen voorkomen en die 
veroorzaakt worden door contact met verwante microorganismen die een grote 
antigene overeenkomst verlonen zoals N. catharrhalis en N. meningitidis met N. 
gonorrilOeae, C. pneumonia en C. psittaci met C. trachomatis, en HSVI met HSV2. 
Bij de bestrijding van de sexueel overdraagbare aandoeningen is een gevoelige en 
snelle diagnostische methode belangrijk om door een snelle behandeling de 
infectie-keten te kunnen doorbreken. Het ideaal is een snelle en gevoelige methode 
die verrichl kan worden terwijl de patient er op wac hi, zodat diagnostiek en 
behandeling in een bezoek kan plaalsvinden. Voor dit doel zijn zowel de 
kweekmethode als de serologie voor deze SOAs onvoldoende snel. Daarnaast zijn 
zij meestal te gecompliceerd om beschikbaar te zijn op de plaats waar de diagnose 
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gesteld moet worden. Dit stelt eisen aan het transport omdat sexueel 
overdraagbare ziekteverwekkers slecht overleven onder niet optimale transport 
omstandigheden en het resuHaat van de kweek ongunstig beinvloed kan worden. 
Dit zijn de redenen dat er gezocht is en wordt naar alternatieve methoden ter 
opsporing van de ziekteverwekkers. Deze berusten op: 
1. antigeendetectie: antilichamen tegen het microorganisme, opgewekt in 
proefdieren worden gebruikt om in patientenmateriaal de ziekteverwekker aan te 
tonen. 
2. het aantonen van het DNA of RNA van het microorganisme. 
3. de vermeerdering van het DNA of RNA, dat vervolgens wordt aangetoond als 
bewijs voor de aanwezigheid van het microorganisme. 
Daarnaast is getracht om bij het ontwikkelen van diagnostische methoden de voor 
de patienten belastende onderzoeken van de cervix, de urethra, het rectum en de 
oropharynx overbodig te maken. Bovendien kunnen specifieke en sensitieve testen 
screening van bepaalde bevolkingsgroepen mogelijk maken. 
Ten tijde dat het in de hoofdstukken 4-7 beschreven onderzoek verricht werd, was 
de aandacht sterk gericht op antigeen detecterende methoden, die veelal werden 
uitgevoerd in een ELISA opstelling. Voordelen van dit type testen is de snelheid en 
eenvoud van uitvoering, de mogelijkheid tot automatiseren en de mogelijkheid ook 
niet meer levende sexueel overdraagbare ziekteverwekkers aan te tonen. De 
ELISA methode voor het aantonen van C. trachomatis en in mindere mate de 
ELISA voor het aantonen van N. gonorrhoeae zijn doorgedrongen tot het routine-
laboratorium. Voor herpes simplex virus zijn deze methoden niet verder gekomen 
dan het research laboratorium. De commercieel beschikbare ELiSAs zijn niet 
goedkoop. De voordelen komen slechts volledig tot hun recht bij een voldoende 
groot aanbod van patientenmonsters. Bij een minder groot aanbod worden deze 
testen uit economische overwegingen "badge-gewijze" uitgevoerd, waardoor het 
voordeel van I)et snel verkrijgen van de uitslag vervall. Per laboratorium en per 
microorganisme kan de balans tussen voor- en nadelen anders uitvallen. 
De moleculair biologiscl)e detectiemethoden zoals hybridisatie en peR staan thans 
sterk in de belangstelling. De sensitiviteit van de commercieel verkrijgbare 
hybridisatie testen, de probe assays voor C. trachomatis en N. gonorrhoeae bleek 
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niet groter dan die van de respeclievelijke ELiSAs, dit in tegenstelling tot die van 
de peR. Deze techniek is zeer gevoelig, in principe kan sen organisme in het 
palientenmateriaal gedetecteerd worden. Aanvankelijk was de slechte specificiteit 
van de peR een belangrijk nadeel, dat overwonnen Iijkt te zijn door het toepassen 
van gesloten systemen. Een verder voordeel is de mogelijkheid in een monster met 
behulp van verschillende primers meerdere rnicroorganismen aan te tonen. Met 
deze test zal het in de toekomst mogelijk zijn een infeclie met C. Irachomatis en N. 
gonorrhoea bij mannen vast te stellen mbv urinemonsters. Hierdoor kan het 
afnemen van het urethramonster worden vermeden, waardoor de belasting voor de 
patient verder afneemt. Voor deze testen is de aanwezigheid van levende microor-
gansrnen niet noodzakelijk, zodat geen verlies van sensitiviteit optreedt door niet 
optimale transport omstandigheden. 
Er kleven ook nadelen aan deze rnethoden. Zo is het microorganisrne niet beschik-
baar voor gevoeligheidsbepalingen en typeringen, met name van be lang bij N. 
gonorrhoeae. Daarnaast is een kwantificering van het gevonden microorganisrne 
niet mogelijk, het resultaat is posilief of negatief, zonder gradaties. De mogelijkheid 
zeer kleine aantallen microorganismen op te sporen wordt in het geval van C. 
trachomatis door sommigen wei als een nadeel beschouwd, aangezien het slechts 
een commensaal zou betreffen. Echter, daar het hier gaat om een sexueel 
overdraagbaar microorganisme, waarbij het van be lang is ook asymptomatische 
dragers op te sporen en te behandelen, dient bij deze opvatting een vraagteken 
geplaatst Ie worden. 
Wegens de vele nadelen die aan de kweek van chlamydia kleven, is vooral voor dit 
organisme naar alternatieven gezocht. Dit waren aanvankelijk de ELISA en de IF 
voor antigeen deteclie, later zijn daar de probe assay en peR bijgekomen. Een 
overzicht van de verschillende technieken is gegeven in Hoofdstuk 3. In de 
Hoofdstukken 4 en 5 werd een ELISA voor deteclie van Chlamydia Irachomatis 
antigeen geevalueerd. 
In Hoofdstuk 4 is het onderzoek van 403 urethramonsters van mannen beschre-
ven. De palienten werden ingedeeld in groepen, afhankelijk van de ernst van de 
symptom en en afwijkingen in het urine-sediment. De sensitiviteit van de ELISA 
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I.o.v. de kweek varieerde van 50% in de groep zonder symptomen of sedi-
mentsafwijkingen tot 82% in de groep met postgonococcal urethritis. Andere 
auteurs vonden voor de ELISA, verricht met urethra monsters van mannen een 
sensitiviteit, die varieerde van 66-100% [1-8). 
In Hoofdsluk 5 is het onderzoek met de ELISA van celVixmonsters, afkomstig van 
246 vrouwen, waaronder begrepen de 135 vrouwen, die in Hoofdstuk 4 werden 
vermeld, beschreven. In de celVix uitstrijkjes werd een semi-quantitatieve bepaling 
van het aantal leucocyten verricht, waarbij werd gescoord van 0 (geen leucocyten 
aanwezig) tot 4 (>20 leucocyten/microscopisch veld). De sensitiviteit van de ELISA 
I.o.v. de kweek varieerde van 50 % in de groep met 0 leucocyten tot 100 % in de 
groep met meer dan 20 leucocyten. Daarnaast werd een indeting gemaakt op basis 
van de resultaten van de kweek. Er bleek een significant verschil tussen beide 
groepen in de resultaten van de ELISA: de sensitiviteit bedroeg 54 % bij patiente-
nmonsters met < 20 inclusies en 100 % bij >20 inclusies in de kweek. Deze 
resultaten suggeren dat de sensitiviteit van de ELISA afhangt van de hoeveelheid 
antigeen. Er werd een overall sensitivity van 67% voor de ELISA I.o.v. de kweek 
gevonden. In studies van anderen varieerde de sensitiviteit van de ELISA verricht 
met celVixmonsters van 71 tot 98% [1,3,4,7-10). 
De gevonden resultaten voor de sensitiviteit lopen nogal uiteen. HielVoor zijn 
verschillende oorzaken aan te wijzen: 
1. De referentietesl. Door de meeste onderzoekers wordt de kweek als referentie 
gebruikl. Deze is echter niet gestandaardiseerd en kan plaats vinden op diverse 
cellijnen zoals de HeLa 229 en Mc Coy cellijnen, die ook nog op diverse manieren 
voorbehandeld kunnen zijn met bijv. DEAE-dextran of Cytochalazine B. Tevens 
kunnen er slechts een, maar ook meerdere passages worden uitgevoerd. T enslotte 
kan de identificatie op diverse manieren plaatsvinden. Kleuring met jodium is 
relatief ongevoelig, kleuring met Giemsa, gevolgd door beoordeling onder 
donkelVeld-belichting is gevoetiger. Identificatie met behulp van immuno-
fluorescentie is de gevoeligste methode. Het zal duidelijk zijn dat de gevonden 
sensitiviteit van de ELISA al zal hangen van de sensitiviteit van de gebruikte 
kweek-methode. 
2. De samenstelling van de geteste patientengroep. Het maken van onderscheid 
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naar klinische beeld, leucocytenscore of sedimentsafwijkingen is van groot belang 
bij de bepating van de sensitiviteit van de ELISA, zoals blijkt uit onze studie en die 
van anderen [5,6,11-13]. 
3. Een juiste monsterafname is bij de Chlamydia diagnostiek essentieel. Omdat het 
een intracellulair microorganisme betreft moet het monster voldoende cellen 
bevatten. Een slechte monster-afname zal resulteren in een lager antigeen aanbod. 
Ook de volgorde waarin de monsters voor de kweek en de ELISA werden 
afgenomen bleek, althans bij mannen, de resultaten te beinvloeden [4,11]. Taylor 
Robinson toonde in een muizen-model aan dat de sensitiviteit van de ELISA voor 
het aantonen van C. trachoma!is vergeleken met de kweek afhankelijk was van de 
volgorde van het afnemen van de monsters [14]. 
Ook de wijze van transport kan van invloed zijn, doordat aantasting van de viability 
van de microorganismen slechts invloed heeft op de resultaten van de kweek. De 
onbekendheid met deze verschillende factoren belemmert de mogelijkheid tot een 
directe vergelijking van de resultaten van de diverse studies. 
De specificiteit van de ELISA werd bepaald met behulp van monsters verkregen 
van bezoekers van de poliktiniek, die negatief scoorden in de Chlamydia kweek. 
Voor mannen bedroeg de specificiteit 98.5 % en voor vrouwen 92 %. Deze getallen 
zijn in goede overeenstemming met die in de literatuur, welke varieren van 94.7% 
tot 98% [6,13,15]. 
Samenvattend, de waarde van de ELISA voor antigeen detectie bij de diagnostiek 
van C.!rachomatis infecties is beperkt, met name door de lage sensitiviteit van de 
test. Daar waar de kweek niet beschikbaar is of het transport van het monster 
onder niet-optimale omstandigheden verloopt, zou de test een plaats kunnen 
hebben. Echter, zoals in Hoofdstukken 5 en 6 is aangetoond, dient men zich te 
realiseren dat de test bij de helft van de patienten met een lage hoeveelheid 
chlamydia-antigeen en/of weinig klinische verschijnselen negatief zal uitvallen. 
In Hoofdstuk 6 werd een gemodificeerde versie van een reeds eerder op de markt 
verschenen ELISA test voor het aantonen van gonokokken antigeen, de 
Gonozyme, geevalueerd. Omdat in eerdere studies het resultaat bij vrouwen teleur-
stellend was [16], werd in deze studie de test geevalueerd met behulp van cervix-
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monsters en urethramonsters van 266 prostituses. De prevalenlie van gonorrhoea 
op basis van de kweek was ondanks de regelmalige con troles van deze vrouwen 
vrij hoog, namelijk 9.3%. Wegens het vermoeden dat de volgorde waarin de 
monsters werden algenomen de resultaten zou kunnen beinvloeden, werd besloten 
de afname-volgorde te randomiseren. De sensilivileit van de ELISA bedroeg 88% 
(urethra) en 91 % (cervix) indien de wattenstok voor de ELISA het eerste werd 
afgenomen en respectivelijk 56% en 85% als de wattenstok voor de kweek het 
eerste werd afgenomen. De overall sensitiviteit van de ELISA verricht met urethra 
monsters was 71 %, de specificileit was 98,9%. Voor de cervixmonsters werd voor 
de ELISA ten opzichte van de kweek een overall sensitiviteit van 88% en een 
specificiteit van 99.2% gevonden. De voorspellende waarde van een negatieve 
cervix test was hoog (98.9%), zodat deze test geschikt werd geacht voor het 
screenen op gonorrhoea bij deze groep vrouwen. Deze resultaten komen overeen 
met de resultaten (sensiliviteit 87.5%, specificileit 98%) van een andere studie [17]. 
Echter, Papasian et al. vonden een veel lagere sensiliviteit voor de Gonozyme in 
cervix monsters, namelijk 74.4%. De specificiteil was eveneens 99.2% [18]. In 
eerdere studies was reeds gebleken, dat de Gonozyme bij urethra-monsters van 
mannen uilstekend voldeed met een sensilivileit van 90-100% [17] en 97.3% [18]. 
Het vergelijken van de resultaten van de diverse onderzoekers wordt bemoeilijkt 
door soortgelijke factoren als in de vorige paragraaf: verschil in referentietest, 
verschillen in de samenstelling van de palientengroepen en verschil in monster-
afname. Zo zullen vancomycine gevoelige stammen in de kweek gemist kunnen 
worden als een seleclieve voedingsbodem wordt gebruikt. Net als bij de 
Chlamydiazyme blijkt ook de sensiliviteit van de Gonozyme af te nemen, wanneer 
patientenmonsters, die weinig antigeen bevatten, worden gebruikt [17, 18]. 
Samenvattend, met de ELISA worden uitstekende resultaten verkregen bij mannen 
met symptomen van urethritis. Echter, de ELISA heeft in deze groep nauwelijks 
voordelen boven het veel goedkopere en snellere Grampreparaat. V~~r vrouwen is 
de siluatie anders, omdat het Grampreparaat van urethra en cervix ongevoelig is. 
Hier is de ELISA een goed alternatief voor het Grampreparaat en de kweek. Dil 
laatste geldt met name wanneer het transport van de monsters niet optimaal is, 
daar de resultaten van de ELISA niet worden beinvloed door niet-optimale transpor-
164 
tomstandigheden ot gekoeld bewaren van de monsters gedurende een periode van 
14-26 dagen. Verder heef! de ELISA voordelen als de diagnose snel gewenst 
word!. Van dit voordeel wordt gebruik gemaakt in Rotterdam, waar de ELISA wordt 
gebruikt voor de wekelijkse screening van sex-clubvrouwen en prostituees. 
Voor het detecteren van HSV is de kweek de meest gevoelige en specifieke 
methode, door de combinatie met IF wordt het virus tevens getypeerd. Echter, het 
duurt 1 tot 10 dagen voor het ePE zichtbaar word!. Er zijn diverse ELISA systemen 
ontwikkeld, waarbij het resultaat sneller bekend is. In de studie beschreven in 
Hoofdsluk 7 werd een ELISA voor het aantonen van HSV (Abbot, USA) 
vergeleken met de kweek, bij patienten met genitale laesies verdacht voor HSV 
intectie. De sensitiviteit van de ELISA ten opzichte van de kweek bedroeg 76.9%, 
de specificiteit 100 %. Bij vergelijken van de diverse patientengroepen bleek de 
sensitiviteit van de ELISA het hoogste in de monsters atkomstig van patienten met 
blaasjes of ulcera (87%). De sensitiviteit van de ELISA was ook hoger in monsters 
die in de kweek binnen 48 uur een ePE veroorzaakten (100% voor HSV1, 92% 
voor HSV2). Dit suggereert dat de resuitaten met de ELISA beter zijn naarmate de 
monsters meer virusdeeltjes bevatten. 
Diverse ELISA systemen (Dako, Ortho, Herpcheck, Welcome, Novo) zijn 
geevalueerd door verschillende onderzoekers [19-27}. De specificiteit was bij aile 
testen hoog (93-100%), echter de gevonden sensitiviteiten lopen nogal uiteen, 
(34.3-98.6%) athankelijk van de soort test, de onderzoeker en de onderzochte 
patientengroep. In het algemeen was de gevonden sensitiviteit laag bij cervix-
monsters van asymptomatische vrouwen [21,22,26}. De sensitiviteit was hoger bij 
monsters van laesies, atgenomen bij patienten met symptomen [25,26}. Bij deze 
laatste groep bleek bovendien dat de sensitiviteit van de ELISA hoger was 
naarmate de monsters atkomstig waren van laesies in een vroeger stadium [25}. 
Het blijkt dat de ELISA testen voor het aantonen van HSV -antigeen een goede 
specificiteit hebben, maar dat de gevoeligheid te wensen over laa!. De sensitiviteit 
is het hoogste in monsters van patienten met symptomen en laesies in een vroeg 
stadium, welke veel antigeen bevatten. Dit zijn echter dezelfde monsters die in de 
kweek binnen 48 uur ePE vertonen, zodat in deze gevallen de uiteindelijke tijdwinst 
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gering is. Bij patienten zonder symptomen of met laesies in een laat stadium voegt 
deze test weinig toe aan de bestaande diagnostiek. Echter, hier biedt serologisch 
onderzoek extra informatie, zoals blijkt in Hoofdsluk 8. 
Hierin wordt de evaluatie van twee serologische testen voor het aantonen van type-
specifieke antilichamen tegen HSV -2 beschreven. De resultaten van de dot 
immunobinding assay (DIA) met gG2 als antigeen, dat is gezuiverd door affiniteits-
chromatografie met behulp van gel-gebonden Helix pomatia lectine, zijn vergeleken 
met de resultaten van de Western Blot Analyse (WBA) en de kweek. Hiertoe 
werden sera van 219 patienten, ingedeeld in diverse groepen, afhankelijk van het 
gekweekte virustype en de symptomen, getes!. Van 44 patienten met recidiverende 
HSV-2 infecties waren er 39 (88%) positief in de DIA en 41 (93%) in de WBA. In 
82 sera van patienten, afgenomen 1-5 weken na het begin van de eerste 
symptomen, was de gevoeligheid van beide testen vee I lager: 20% voor de DIA en 
40% voor de WBA. De testen bleken be ide zeer specifiek: in 50 sera van 
schoolkinderen werden noch met de DIA noch met de WBA antilichamen tegen 
HSV-2 gevonden. De WBA is gevoeliger dan de DIA, maar is in een routine 
laboratorium nauwelijks uitvoerbaar, omdat hieNoor specialistische apparatuur 
vereist is. De DIA is vee I eenvoudiger. Echter, gezuiverd glycoproteine G2 is tot op 
heden niet commercieel verkrijgbaar. Type specifieke serologische diagnostiek is 
een nuttige aanvulling op de bestaande diagnostiek. Daar waar de kweek niet of 
niet meer mogelijk is, zoals bij patienten met laesies in een laat stadium of bij 
patienten zonder symptomen maar met een specifieke vraagstelling, zoals bij risico-
zwangeren, kan de type-specifieke serologie waardevolle informatie geven. 
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